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MBD1 belongs to the family of proteins with the characteristic Methylated CpG 
Binding Domain (MBD) and plays a very important role in neuronal development and 
division through transcriptional repression of genes involved in that pathway. MBD1 
also reported to be involved in tumor progression, by repressing tumor suppressor 
genes when over expressed, especially in cancer cells. Until now, the MBD domain 
and CXXC domain, which has a cysteine rich zing finger binding domain and tends to 
bind unmethylated DNA, have been characterized but little is known about the 
potential Transcriptional Repressor Domain (TRD), which is involved in recruiting 
binding partners needed for repressor complex formation to suppress a gene through 
promoter methylation. We have solved the structure of TRD using the NMR 
technique and also characterized the mode of its binding with partners. To our 
surprise, such an effective repressor domain is unstructured with little defined 
secondary structures.  TRD tends to bind to its interacting partners weakly, in a 
transient manner, but still with a lot of specificity. It  can be concluded that TRD 
needs to be unstructured to bind several partners, rather than having a specific fold, to 
play a centered role in cell signaling pathways. 
 Mitochondrial Complex I is an important member of Oxidative 
Phosphorylation (OXPHOS) system involved in the production of ATP, which is the 
energy currency for cells. Up to 40% of various mitochondrial metabolic disorders 
that  affect many vital organs of the body occur due to the deficiency in Complex I 
activity. At least six chaperones have been reported to be important for Complex I 
formation, where any mutations of those chaperones affect the function of the 
mitochondrion. MidA is a mitochondrial protein and has been classified as an 
uncharacterized protein with unknown function. Recent studies have revealed the 
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importance of MidA in the stability or assembly of mitochondrial Complex I. MidA 
was identified to be important for the survival of Dictyostelium, where MidA
-
 
knockout cells showed severe phenotypic defects due to the inefficiency of 
mitochondrial function and also knock down of the MidA homologue in humans 
resulted in reduced complex assembly which could result in disease conditions. MidA 
was also found to be interacting with NDUFS2, one of the core subunits of Complex 
I,  an iron-sulfur protein and also possibly a chaperone. I have determined the crystal 
structure of the MidA protein of Dictyostelium with SAM and SAH at a resolution of 
2.9 Å. Based on our sequence, structural and biophysical analyses, we have shown 
that MidA has a conserved methyltransferase motif I and and confirmed SAM binding 
property. We propose that MidA is a class I methyltransferase. Based on the earlier 
information that MidA interacts with the N-terminal 40 residues of NDUFS2, I have 
made a MidA: NDUFS2 complex model by docking a 3D model of NDUFS2 with our 
MidA structure. . The MidA: NDUFS2 model is quite convincing that MidA forms a 
specific fold via an interaction of its N-terminal helices with its C-terminal region and  
then is involved in binding to NDUFS2, which could be a possible substrate. 
However, this hypothesis should be further supported experimentally. The crystal 
structure of the MidA: NDUFS2 complex is a potential future goal to understand the 
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CHAPTER 1. STRUCTURE DETERMINATION METHODS 
 
1.1  INTRODCUTION  
Proteins decide the fate of cells, whether to survive or to die, and this decision 
will be executed by its 3-dimensional structure. The structure of proteins can be 
determined by techniques such as Nuclear Magnetic Resonance (NMR), X-ray 
crystallography and cryo-Electron Microscopy (cryo-EM). The ultimate goal is to 
decipher the role of these bio-machineries that are present in every cell of all living 
beings. However, each technique has its own limitations and more importantly it 
depends on several physical characteristics of proteins. Since the first NMR structure 
of protein inhibitor IIA from the bull seminal plasma (BUSI IIA, 6 kDa), NMR 
spectroscopy has emerged as one of the important techniques in solving protein 
structure. With the ongoing efforts to overcome the protein size barrier, new advances 
include higher multi-dimensional spectra, selective labeling for much larger proteins 










more dedicated attempts such as deuteration, near-automation and improved 
dimension spectroscopy fasten and ease peak assignments. Furthermore, NMR 
spectroscopy is not limited to the flexibility of a folded or unfolded protein. 
On the other hand, X-ray crystallography has the advantage of obtaining 
structures of even bigger proteins. Although X-ray crystallography is not limited by 
protein size, still several bottlenecks including obtaining diffraction quality crystals 
impede the flow of structure determination. In recent time, the cryo-EM technique 
with at resolution of about 3.5 Å for a protein of more than 200 kDa is receiving much 
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attention. With proper combination of these three techniques, we will be able to study 
proteins of 50 residues to protein complexes of several kDa.  
 
1.2  BASICS OF NMR SPECTROSCOPY  
NMR stands for Nuclear Magnetic Resonance which can be employed for 
determining the structure of chemical compounds and proteins, and also it is used in 
other fields such as medicine for imaging. NMR depends on the magnetic nuclei 
present in the atom, so that it can align toward the magnetic field when applied to it 
and also it absorbs Radio Frequency (RF) when it is close to its resonance frequency. 
Thus absorbed Radio Frequency will give signal in NMR data collection and in 







C, etc have spin quantum number 1/2 and they are used for 
solving structures of proteins. For simple chemical compounds such as small 
molecules, the data obtained from 
1
H chemical shift can be employed to interpret the 
structure. But in the meantime, proteins are macromolecules with multiple amino 
acids and thus the information obtained from 1D NMR, will give only basic idea 
about protein folding and also there will be a huge overlap of signal between different 





could provide us information about the three dimensional structure of the proteins 
from the peak shift of each amino acid present in the proteins and also the vicinity of 
each amino acid related to the other amino acid could be obtained, which would help 
us to study the structures of proteins. Thus NMR can be applied to various fields of 
chemistry and structural biology to determine the structures and to understand the 




1.2.1 NMR active nuclei 
NMR spectroscopic data of proteins depend on the presence of nuclear spins. 
Nuclei with odd mass will have spin quantum numbers of half-integral; nuclei of even 
mass with an odd proton number will have an integral spin quantum number. While 
the above two are active for NMR, even mass nuclei with an even proton number 
(e.g., 
12
C) will have a spin quantum number of zero and are inactive for NMR (Table 
1.1). 
 
Table 1.1 Properties of some selected NMR nuclei. 















H  1/2  99.98  26.7519  1.00  1.00  
2
H  1  0.016  4.1066  9.65 · 10
-6




C  0  98.9  --  --  --  
13
C  1/2  1.108  6.7283  1.59 · 10
-2




N  1  99.63  1.9338  1.01 · 10
-3




N  1/2  0.37  -2.712  1.04 · 10
-3




O  0  98.9  --  --  --  
17
O  5/2  0.037  -3.6279  2.91 · 10
-2




P  1/2  100  10.841  6.63 · 10
-2














P) and the nuclei with 
I = 1 [
2
H (deuteron)] give more important information. The quadrupolar nuclei with I 
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> ½, have more efficient nuclear spin relaxation and the magnetic state lifespan of it 
will be shorter and gives broader NMR signal, thus nuclei with I = ½ are usually more 
preferred and comparatively easier to study. 
Nuclei having nonzero spin angular momentum also have nuclear magnetic 
moments. The Wigner-Eckart theorem is generally defined by equation 1.1:  
μ = γI      (1.1) 
where μ, the nuclear magnetic moment is co-linear with I, the nuclear spin angular 
momentum vector, for a nucleus characterized by its gyromagnetic ratio γ. In the 
presence of an external magnetic field, the energies of the spin states of a nucleus are 
defined by equation 1.2:  
E = - μB     (1.2)  
where B is the magnetic field vector.  







with only two nuclear spin states, m = +½ and -½ and two energy levels separated by 
ΔE = γħB0. In addition, the sensitivity of NMR signal is proportional to γ
3
 and among 
the three nuclei, 
1
H has the highest magnetogyric ratio γ, which is four times that of 
13




H nuclei have the highest γ, the 1H spins, due to 
dipole-dipole interactions, have the most efficient relaxation, providing Nuclear 
Overhauser Effects (NOEs), which are useful to determine the internuclear distances 
for a protein fold. Thus NMR solution structures can also be described as protonic 
structures. 
 
1.2.2  Radiofrequency and free induction decay  
Pulsed NMR are usually employed to disturb the thermal equilibrium state of 
the bulk magnetic moment of nuclei in a conditional static magnetic field (B0) to 
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create an NMR free induction decay (FID) signal. Short radiofrequency (RF) bursts 
with pulse width in microseconds at first displace this equilibrium magnetization by a 
flip angle θ = γB1tp in radians, whereas B1 is the RF field strength and tp is the pulse 
width. In the absence of an RF field, the bulk magnetization of the non-equilibrium 
nuclei moves over the z-axis (the static field) with an angular Larmor frequency ω0 = 
- γB0 that is detected by a receiving coil. As the nuclear spins restore thermal or 
Boltzmann equilibrium, the precession releases energy in the form of sinusoidal RF 
waves or NMR signal. However this NMR signal will decay in the order of seconds, 
hence the term FID. The change of magnetization with time can be described by two 
first-order processes, spin-lattice and spin-spin relaxations. Spin-lattice relaxation 
shows the restoration of the longitudinal magnetization and the spin-spin relaxation 
shows the decay of the transverse magnetization in the x-y plane. 
 
1.2.3  Phasing 
The acquired NMR spectra often have both the absorptive and dispersive 
signals in the place of the Lorentzian absorptive signal, partly due to delays in pulse 
sequence between excitation and reception. Hence we have to correct the spectra by 
phasing two parameters, the zero-order phase, which is frequency independent and the 
first-order phasing, which is frequency dependent. 
 
1.2.4  Chemical shift 
Chemical shift is the result of the nucleus surrounded by anisotropic electronic 
environment and in general chemical shift is the electronic effect resulting from the 
static magnetic field and secondary magnetic shielding created by neighboring 
electrons, and used for residue assignments. This electronic effect is associated with 
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two phenomena, chemical exchange and chemical shift relaxation. Chemical 
exchange occurs when a nucleus is made to undergo conformational transition or a 
new chemical environment such as addition of a ligand and change in the 
environment parameters suc as pH, temperature, etc. Relaxation is due to the drop of 
an excited nucleus back to its ground state.  
With the help of chemical shift differences, a chemical shift index (CSI) plot, 
based on deviations from known random coil values of Hα, Cα, Hβ and Cβ can predict 
secondary structure patterns in a protein. A combined chemical shift perturbation 
(CCSP) plot is based on the peak relocation upon addition of a ligand and it can be 
used to identify perturbed residues in a protein, which is binding to the ligand. 
Although the chemical shift effect for 
1
H relaxation is small, until it is placed in a 
very large static magnetic field, an increase in magnetic field provides improved 
signal-to-noise ratio and will increase chemical shift relaxation and broaden the 
resonance of linewidths of nuclei, such as 
13




1.2.5 Chemical exchange  
Chemical exchange occurs due to the exchange of a nucleus between two or 
more distinct chemical environments in a time-dependent manner. The simple model 
of such an exchange is interconversion between only two states such as an exchange 
between ligand-free ↔ ligand-bound states of a protein, monomer ↔ dimer, 
protonated ↔ deprotonated, or conformations A ↔ B (Fig. 1.1a). A simple two 
system state for NMR can be defined as the two states having resonance frequencies 
νA and νB and a chemical shift difference Δν = |νA − νB|. The appearance of the 
corresponding NMR spectrum relies on the populations of both the states, PA and PB, 
and the relative values of the exchange rate kex = kA + kB and the chemical shift 
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difference Δν. kex quantifies the average number of stochastic exchange occurrences 
per unit time. kex and Δν can be compared directly since they will be having the same 
units. The effect of varying kex is shown in the NMR spectrum (Fig. 1.1b). 
 
Figure 1.1. Chemical exchanges directly alter the three primary 
NMR observables. (a) Exchange between two states A and B can be 
described by their rates of departure kA and kB and chemical shifts νA 
and νB. kex is the total exchange rate and PA and PB are the population 
fractions of each state (PA + PB = 1). (b) The effect of varying kex on 
NMR spectra with PA = 75% and Δν = 100 Hz. Adapted from: Yang, 
Zheng et al. 2004. 
 
1.2.6  J-coupling  
J-coupling is an indirect scalar interaction obtained from hyperfine 
interactions between nuclei and local electrons which occur between the two nuclear 
spins. The magnitude of J-coupling increases corresponding to the smaller number of 
bonds separating the two nuclei. Different amino acid residues can be distinguished 
based on J-coupling interactions obtained from NMR spectra (e.g., HSQC, HNCO 
and H(CCO)NH). In addition to that, the Karplus equation relating the 3J-coupling 
constant to dihedral angles is very useful for defining a protein structure. For 
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example, the main-chain torsion angle φ from 3JHNHα and side-chain torsion angle 
χ1 from 3JHαHβ annotates the main chain and side-chain conformations of a peptide. 
Values of 3JHNHα are also used to index secondary structures in a protein, ranging 8-
10 Hz (for β-sheets), 3-5 Hz (for α-helix) and 6-7.5 Hz (for random coil). Hence J-
coupling is generally used to define a spin-system and the secondary structure of a 
protein. 
 
1.2.7  Nuclear overhauser effect 
The Nuclear Overhauser Effect (NOE) is the transfer of dipolar cross-
relaxations between nuclear spins through space. In steady-state NOE for a two-spin, 
a low power but specific RF will equalize the average populations (α state = β state) 
of only I-spin by saturation. In the event of restoring Boltzmann population (α state > 
β state), I-spin relaxes via W0, W1, I and W2 processes. However, only W0 and W2 
relaxations will modify the population difference across α and β energy states of S-
spin via cross-relaxation within < 5 – 6 Å, thus creating NOE observed at S-spin (Fig. 
1.2). 
   
Figure 1.2. Transition processes for two-spin IS system. Energy α 
and β states for I-spin (red) and S-spin (black). Adapted from: 






1.2.8  Relaxation  
In NMR spectroscopy, the term “relaxation” can be defined as the return of 
nuclear magnetization to equilibrium. For an isotropic system (there is no chemical 
exchange), the relaxation process is typically represented by two independent and 
different rate constants, the longitudinal relaxation rate (R1) and transverse relaxation 
rate (R2) or their reciprocal relaxation time T1 (T1 = R1
-1
) and T2 (T2 = R2
-1
), 
respectively. For small molecules, the relaxation rates are measured using the 1D 
method but for proteins, they are determined on the same principle but using the 2D 
HSQC-based approach. 
The T1 (or spin-lattice relaxation time) is measured along the z-axis employing 
its decay with the inversion recovery (IR) method. For IR pulse sequence Td-180x°-τ-
90x°-FID, the time to come back to ground state of the excited magnetization along 
the z-axis back to equilibrium is defined by Equation 1.3:  
Mz(t) = Mz(∞)(1-2e
-t/T
1)   (1.3)  
T1 is then measured by using a series of interval τ values, where T1 = τ/ln2 at node 
intensity, Mz(τ) = 0 when Td > 5T1 interval.  
The T2 (or spin-spin relaxation time) is measured by the J-coupling of spins 
with various Larmor frequencies but can be precisely measured for heteronuclear 
spins (e.g., 
15
N) using spin-echo variant experiments [e.g., Carr-Purcell-Meiboom-Gill 
(CPMG)]. The rate of recovery is similar to T1 in an exponential form but the 
amplitude of magnetization reduces quickly in the x-y plane than the z-direction. T2 is 
also the T1ρ (rotational relaxation time) in the absence of chemical exchange or 
anisotropy. Generally an unfolded protein has longer T2 and it will be shorter for 
larger proteins. For a simple spin-echo pulse sequence Td-90x°-τ-180y°-τ–FID, the 





2   (1.4)  
where t is the total evolution time in the x-y plane and M(0) is the initial 
magnetization. 
For pulse sequence, 90x°-τ (spin-lock)-FID, T1ρ is obtained by fitting Equation 1.5:  
M = M(∞) + (M(0) - M(∞))eτ/T1ρ  (1.5)  
where τ is the spin-lock duration by a continuous wave to irradiate the spins in the 
rotating frame and monitor its decay in a longitudinal-like manner.  
Heteronuclear NOE is another relaxation experiment via cross-relaxation 





N heteronuclear NOE is calculated as the ratio of peak intensities in 
spectra recorded with and without proton saturation to identify flexible regions shown 
by decreased NOE intensities in backbone amides of a protein. Steady-state NOE 
value for each amide residue is calculated using Equation 1.6:  
NOE = Isaturated/Iequilibrium    (1.6) 
 
1.2.9  Structure determination  
If we intend to solve a protein structure, a number of NMR spectra have to be 









N HSQC and 3D HNCA, 3D 
HNCOCA and 3D MQ-(H)CCH-TOCSY were collected for back-bone assignments. 




C NOESY (Yang, Zheng et al. 2004), have taken an additional 




C-time shared 4D 
NOESY without deuteration. Unlike 3D NOESY, 4D NOESY offers a fourth 
dimension to resolve ambiguous peaks due to overlapping in a better way. This is 
particularly helpful for proteins with poorly resolved peaks. Acquired NMR data are 
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then processed using NMRpipe (Xu, Zheng et al. 2006) and later analyzed using in-
house NMRspy program (yangdw.science.nus.edu.sg/Software& 
Scripts/XYZ4D/index.htm). For a 3D (or higher dimensional) spectrum, it can be 
described as a 3D (or higher facet) cube composed of many 2D slices stacked 




N HSQC, all peaks are from backbone amides 
NH (except proline, due to missing NH) and other peaks are from NH side-chains of 
Asn, Arg, Gln, Lys, Trp, etc. The first step is to match a peak to one amide residue. 
To attain the backbone assignment of a protein, 3D HNCA, 3D HN(CO)CA, 3D 




N-edited sub-NOESY are used to 
identify intra-residue and sequential spin-systems which are related with each amide 
(Fig. 1.3). In 3D TOCSY spectrum, the resonances in all spins in a spin system of a 
residue will be seen (Fig. 1.3 a-c). For example in a 3D (H)CCH-TOCSY slice, one 
will see three 
13
C peaks for Glu (Cα, Cβ and Cγ) and five 
13
C peaks for Leu (Cα, Cβ, Cγ 
Cδ1 and Cδ2). After identifying the spin systems, the backbone is connected by 





NOESY sub-spectrum (Fig. 1.3d). On the basis of selective sequence assignments, 












N-edited sub-NOESY spectra. The NOEs are 
extracted as intensities or volumes and can be classified into three (or more) distance 
restraint classes: long (1.8 - 5.5 Å), medium (1.8 - 3.4 Å) and short range (1.8 - 2.4 
Å). A lower bound of 1.8 Å, an approximate van der Waals contact for all restraint 
classes is set to account for nuclei, which are very close but having unobservable 
NOEs. The protonic structure is then calculated using Cyana 2.1 (Herrmann, Güntert 
et al. 2002) based on a series of dihedral and distance restraints and reassignment of 








Figure 1.3. Resonance identification of amides. Backbone 
assignment of (a) Q53, (b) L54 and (c) V55 using HN(CO)CA, HNCA 
and spin systems identified using (H)CCH-TOCSY spectra. (d) 









The 3D structure of a protein defines its function. We are interested in linking 
the structure of a protein to its function using several techniques including site-
directed mutagenesis, chemical shift perturbation, NMR ligand titration and cell based 
study. They will be discussed in more details later for the protein of interest. 
 
1.3 BASICS OF X-RAY CRYSTALLOGRAPHY 
X-ray crystallography is one of the two most important techniques to 
determine 3D structures of proteins and chemical compounds. In crystallography, the 
most important requirement is to get a crystal that diffracts, so that we could gather 
atomic resolution information about the molecule we are analyzing. Chemical 
compounds, which are in general easy to crystallize, diffract to high resolution. 
However, obtaining crystals for macromolecules, such as proteins, DNA or protein-
DNA complexes could be challenging, where we have to optimize crystallization 
conditions to obtain a good crystal that diffracts to a good resolution of at least better 
than 3 Å.  X-ray crystallography has certain advantages over the other structure 
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determination method, nuclear magnetic resonance (NMR). NMR could be used for 
only small proteins of size up to 35 kDa, whereas X-ray crystallography has been 
used to solve even the structure of the whole ribosome (Weixlbaumer, Petry et al. 
2007). 
   Protein crystals are formed when an aggregation of molecules forming a 
particularly ordered self arrangement is formed such that each molecule could be 
related to others following certain symmetry operations. In other words, a crystal is an 
anisotropic, homogeneous body possessing a three-dimensional periodic ordering of 
atoms, ions or molecules. The orderliness and diffraction of these crystals depend 
upon the intermolecular forces among the molecules. A well ordered crystal would 
need proper packing of molecules in a limited space (Helliwell 2005). When X-rays 
impinge on a well formed crystal, they are diffracted to give a diffraction pattern. In 
the place of lens in light microscope, we use computer to generate the arrangement of 
molecules from diffraction images. 
 
1.3.1.  Unit-cell 
In a crystalline state, solute molecules will adopt one among a limited number 
of orientations, when they start to arrange in an ordered manner. An ordered 
arrangement will follow a fixed orientation of each molecule in relation to one 
another. Therefore, it is possible to divide a crystal into a minimum portion, which, 
when repeated multiple times, will generate the whole crystal. This minimal building 
block is known as the unit-cell. The unit-cell has three non coplanar lattice vectors a, 




Figure 1.4. The unit-cell is the repeating building block which forms a 
crystal when repeated several times in accordance to the symmetry 
(Adapted from: http://xrayweb2.chem.ou.edu/notes/symmetry.html). 
 
   The magnitude of the lattice vectors a, b and c along with the angles α, β and γ are 
known as the unit-cell parameters. Based on the unit-cell parameters, every crystal 
can be divided into one among the following 7 crystal systems (Fig. 1.5). Based on 
this classification, one step further would allow the unit-cells to form interlaced 
arrangement (known as unit-cell centering) and the 7 crystal systems form 14 Bravais 
lattices (Fig. 1.6), named after the French physicist Auguste Bravais, who first 
proposed it in 1845. 
 




1.3.2 Point group and space group 
The spatial relationship between the related neighbor motifs is called 
symmetry operations. The three basic symmetry operations followed by crystals are: 
inversion, reflection and rotation. The allowable combinations of these 
crystallographic symmetry operations in a primitive unit-cell of the 7 crystal systems 
are known as the crystallographic point groups. There are 32 point groups. When the 
basic symmetry elements rotation and reflection as well as the point groups are 
subject to translation and combined with the Bravais lattices, 230 possible types of 
crystallographic packing, known as space groups, are generated. Of these 230 space 
groups, many follow the inclusion of enantiomeric motifs. The reason that all proteins 
are made up of only L-amino acids and do not have the enantiomeric D-amino acids, 
will allow them to crystallize only in 65 chiral space groups (Hahn, 2006). 
 
 





1.3.3 Bragg’s law 
Bragg’s law is a condition for a crystal to diffract, when electromagnetic 
radiation, of a wavelength that is comparable to atomic spacing, impinges upon a 
crystalline sample, scattered and undergoes constructive interference. For a crystalline 
solid, W.L. Bragg showed that a set of parallel planes with indices hkl and interplanar 
spacing dhkl produces a diffracted beam when X-rays of wavelength λ impinge upon 
the planes at an angle θ and reflected, also at the same angle, only if θ meets the 
following condition 
2dhkl sinθ = nλ         (1.7)  
where n is an integer (Rhodes, 2000). 
 
Figure 1.7. Bragg’s law. Bragg’s law defines the condition for diffraction (Rhodes, 
2000).  
 
The two planes (Fig. 1.7) represent two parallel rows of lattice points with interplanar 
spacing dhkl. Two rays R1 and R2 are reflected from them at an angle θ. Lines AC are 
drawn from the point of reflection A of R1, perpendicular to ray R2. If ray R2 is 
reflected at B, then the diagram shows that R2 travels the same distance as wave R1 
plus an additional distance of 2BC. Since AB in triangle ABC, is perpendicular to the 
atomic plane and AC is perpendicular to the incident ray, angle CAB equals θ, the 
angle of incidence (two angles are equal if corresponding sides are perpendicular). 
Since ABC is a right-angled triangle, the sine of angle θ is BC/AB or BC/dhkl. Thus 
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BC equals dhkl sin θ, and the additional distance 2BC traveled by ray R2 is 2dhkl sinθ. 
If this difference in path length for rays reflected from successive planes is equal to an 
integral number of wavelengths of the incident X-rays (satisfying equation 1.7), then 
the rays are in phase with each other, resulting in constructive interference to produce 
a strong diffracted beam. 
 
1.3.4 Reciprocal lattice and Ewald sphere 
The concept of reciprocal lattice simplifies the mathematical calculation and 
illustration of diffraction which is obtained through Bragg’s reflections and crystal 
geometry. A crystal, or the array of unit-cells, can be reduced to a set of repeating 
lattice points. The whole 3-dimentional lattice can be sliced using a set of parallel 
imaginary planes in a periodic fashion. The planes are then named as h, k, l, known as 
“Miller indices”, which are the integral number of parts into which the plane divides 
each unit-cell parameter a, b and c, respectively. Therefore, an infinite set of planes 
can be made through the real-space lattice, with each set having a unique value for h, 
k and l. The perpendicular shortest distance between two adjacent parallel planes is 
then represented by the vector ‘dhkl’ and is called the interplanar distance. To convert 
this real space lattice into a reciprocal lattice, a lattice point should be drawn from 
each point in the real-space at a distance of 1/dhkl (represented as d*hkl) and normal to 
the hkl plane. The set of points drawn in this manner form the reciprocal lattice. The 
reciprocal lattice was first used by physicist Paul Ewald to give the general 





Figure 1.8. Ewald’s Sphere. X-ray diffraction pattern due to constructive 
interference by Ewald (figure adapted from: Ewald,1969) 
 
If a sphere of radius ‘r’ = 1/λ is drawn and the incident beam of X-rays hits the real 
space plane (hkl) at ‘O’ at an angle ‘θ’ and gets reflected making an equivalent angle 
COB then AC = sinθ/λ. By geometry, AC=BC, therefore, AB=2AC. Now, as shown 
above, 2AC = 2(sinθ/λ). According to Bragg’s law, 2(sinθ/λ) = 1/dhkl. As described 
earlier, 1/dhkl is equal to d*hkl (Ewald, 1969). Therefore, point ‘B’ can be assumed to 
be a point in the reciprocal lattice and if it coincides with the Ewald sphere then it 
satisfies the Bragg’s law.  
 
Figure 1.9. X-ray Diffraction by Ewald. In geometric interpretation, 
a crystal can be assumed to be at the centre of the Ewald sphere. The 
detector is placed behind the crystal to record diffraction spots 
(adapted from: people.mbi.ucla.edu/sawaya/m230d/Data/data.html). 
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According to the Ewald construction, diffraction from a hkl plane will only occur 
when the corresponding d*hkl lies on the Ewald sphere. Therefore, upon exposing a 
crystal to X-rays, only a few of the reciprocal lattice points will be sampled (Rupp, 
2009). The crystal is, hence, rotated so that the reciprocal lattice also rotates and more 
points intersect with the Ewald sphere and are recorded in the detector (Fig. 1.9).   
 
1.3.5 Structure factor 
In a diffraction experiment, using Bragg’s law and the Ewald construction, it 
is possible to determine where the spot from each hkl plane will get collected on a 
detector with known geometry. The real space lattice also could be obtained from the 
corresponding reciprocal lattice. However, the real space lattice obtained in this 
manner will give only a unit-cell with no information about its molecular contents. In 
order to learn about the molecular contents of a unit-cell, the contribution of each 
atom in the crystal towards each observed Bragg reflection needs to be calculated. In 
other words, the total contribution of all atoms in the direction of a particular hkl 
plane is known as the structure factor of that plane. To do this, each observed 
reflection is deconvoluted into the partial contribution of the individual atomic 
scattering factors (of all atoms in the unit-cell) in the direction of the observed 
reflection. The deconvolution into partial contribution of individual scattering factors 
is performed with the aid of the mathematical concept of complex numbers. 
 
1.3.5.1 Wave as a complex number  
Working with scattering of waves can be simplified with the use of complex 
numbers. A complex number can be represented as ‘a + ib’ where ‘a’ and ‘b’ are the 
‘real’ component and ‘i’ is the imaginary component. In the complex number system, 
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the contribution of the imaginary component lies in an orthogonal direction to the real 
number. The complex number a+ib would then represent ‘a’ units in the x direction 
(real axis) and b units in the y direction (imaginary axis), Fig. 1.10 
 
Figure 1.10. Wave as a complex number. Adapted from: 
http://farside.ph.utexas.edu/teaching/315/Waves/ node72.htm).  
 
Waves can be conveniently represented using this system. The amplitude of a 
wave can be represented by ‘r’ and ‘θ’ can be used to represent the phase angle of the 
wave, (Fig. 1.10). This ‘a+ib’ representation is called the rectangular form of the 
wave and can be used to calculate the properties of waves. 
For instance, the electrons present in the (protein) atoms scatters the incoming 
X-rays and the wavelength of the X-rays is about 1.5 to 0.5 Å, which is of the order of 
the atom diameter, and most of the scattering is in the forward direction. It is also 
known that the X-ray scattering power will correspond to the number of electrons 
present in the particular atom. The X-ray scattering power of an atom decreases with 
increasing scattering angle and is higher for heavier atoms.  
1.3.5.2 Electron density 
As defined earlier, each diffraction spot on the detector is the sum of all 




         
 
   
                           
where ‘fj’ represents the atomic scattering factor of atom ‘j’, hkl represent the Miller 
indices of the plane that is forming the Bragg reflection while x, y and z represent the 
fractional coordinates of atom j in the unit-cell. The atomic scattering factor of an 
atom decays with sinθ/λ. From the structure factors of all diffraction spots in an 
experiment, it is now desirable to compute the electron density at each point within 
the unit-cell which provides us a picture of the electron cloud of each atom, thereby 
locating the atom in the unit-cell. The relationship between the reciprocal space 
structure factors to the real space electron density is explained by the mathematical 
formulation of Fourier transformation, developed by the French mathematician Jean 
Baptiste Joseph Fourier. Using the principles of Fourier analysis, the calculation of 
electron density is a reverse Fourier transform of structure factors (Eq. 1.9), where V= 
volume of the entire unit cell.  
           
 
 







      
                         
To visualize the 3-dimentional structure of a protein, it is important to 
determine the location of each atom in the unit-cell of a protein crystal. As is evident 
from the above two equations 1.8 and 1.9, the problem of calculating the location of 
each atom in the unit-cell depends on the structure factor of as much reflections as 
possible, where the structure factor can be calculated by summing up the atomic 
scattering contribution, which in turn depends on the position of the atoms in the unit-
cell. Thus the required solution of a problem depends on the problem itself. A 
technological inability limits the complete determination of experimental structure 
factors, due to the fact that structure factors are composed of experimentally 
measurable structure amplitude as well as immeasurable phase angles of the 
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diffraction waves. This phase problem of crystallography, in both small molecular and 
macromolecular, therefore, is reduced to the problem of accurately estimating the 
phase angles of diffracted reflections, with respect to the undiffracted ray at the 
origin. 
 
1.3.6 Methods to solve the phase problem 
As it is not possible to obtain the phase angles experimentally for all the spots 
recorded on the detector, it is possible to estimate and derive them indirectly or directly 
from the reflections. The method or strategy chosen for solving the phase problem 
depends on some considerations. In spite, all methods help us obtain enough initial phase 
angles to enable the development of interpretable electron density maps. Once we attain 
interpretable electron density map, a partial model of the protein can be built which then 
have to be refined to optimize selected parameters iteratively. Additional phases are then 
derived from the partial model to further improve the electron density maps and build 
more regions of the structure. Statistical parameters obtained from the model are analyzed 
at each step of model building and refinement to verify conformity with the 
experimentally obtained data. Iterative cycles of model building and refinement, while 
comparing the conformity with experimentally obtained data, therefore, gradually 
improves the electron density maps to yield the final structure. The final structure is, 
hence, a model whose conformity has adequately been refined using the experimental 
data. 
 
1.3.6.1. Multi-wavelength anomalous dispersion (MAD) 
Phases can be extracted by using the property of elements to absorb X-rays at 
a particular wavelength. The absorption of X-rays by atoms drops suddenly close to a 
characteristic wavelength(s), known as the absorption edge(s) of the element. When 
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data are collected at the absorption edge, Freidel’s rule does not apply and Ih,k,l ≠ I-h,-k,-
l. Certain atoms, such as selenium and sulphur, absorb at particular wavelengths that 
can be easily generated in today’s synchrotron radiation facilities and can be 
effectively used in labeling a crystal for solving a structure with the MAD method. 
The scattering at the absorption edge is called anomalous scattering and can be 
characterized as, 
   
λ     
λ   Δ   Δ       (1.10) 
where, ΔFr and ΔFi are the real and imaginary components of the scattering 
contribution.    
λ   and   
λ   are the structure factors of the heavy atom derivatized 
protein crystal at a wavelength where it does and does not show anomalous scattering 







 = - αhkl
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 are mirror images of each other at the anomalous wavelength. In 
addition, the imaginary contributions are inverted reflections of each other, i.e., ΔFi+ 
are a reflection of ΔFi
-
 with the direction reversed. A Patterson function (detailed in 
the following part) can be used to locate the heavy atoms in the unit-cell and obtain 
the complete values of ΔFr and ΔFi. In order to break the phase ambiguity, data from 
another wavelength is needed, where phase ambiguity is better illustrated in the 
following Harker construction (Fig. 1.11). The two phases which are possibly present, 
where the circles intersect. The problem then arises as to which phase to choose. This 
requires a consideration of phase probabilities (Taylor 2003). To circumvent it, help is 
taken from the fact that the real and imaginary anomalous scattering factors, ΔFr and 
ΔFi, vary greatly at the absorption edge. Close to the absorption edge ΔFr reaches a 
minimum value and as it begins to ascend, ΔFi reaches a maximum value. These two 
wavelengths, therefore, can be used for exploiting the anomalous behavior while a 
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wavelength far from the absorption edge can be used for exploiting the non-
anomalous behavior of atoms during diffraction. 
 
 
Figure 1.11. Harker Construction.  Harker Construction for Single Isomorphous 
Replacement (SIR). Figure Adapted from (Taylor 2003) 
1.3.6.2 Multiple isomorphous replacement (MIR) 
In this method, a crystal is soaked in a heavy atom solution or a protein is co-
crystallized with a heavy atom. The addition of the heavy atom must not affect the 
crystal formation, protein conformation or unit-cell dimensions, in comparison to its 
native form. In other words, the native and the derivative crystals should be truly 
isomorphic (Taylor 2003). Data sets from native and heavy-atom derivative crystals 
are collected. Interpretation of difference Patterson maps will reveal the locations of 
heavy atoms in the unit-cell, from which the phases of reflections can be computed. 
Since the structure factor of the heavy atom derivative (Fph) is the vector sum of the 
lone heavy atom (Fh) and the native crystal (Fp), the phase of the native Fp can be 
solved geometrically from the equation 
Fph = Fp + Fh     (1.11) 
      or, 




1.3.6.3 Patterson function 
The Patterson function is crucial for determining the sub-structure of heavy 
atoms and is analogous to Eq. 1.9, which is used to calculate electron density from 
structure factors, albeit with a variation. It is a Fourier series that uses only the 
amplitude of the structure factors and does not use the phase (Eq. 1.12). As the 
structure factor amplitudes can be directly derived from spot intensities, no additional 
information is required for calculating a Patterson map. 
           
 
 
        




       
 
 
 A Patterson map constructed using Eq. 1.12 produces 
peaks at the heads of vectors drawn from every atom to all atoms, including itself, in 
the unit-cell. The peaks in the Patterson map are also referred to as Patterson atoms. 
Therefore, if there are n atoms in a unit-cell, then there would be n (n-1) Patterson 
atoms in the Patterson unit-cell. The enormity of the number of peaks makes 
interpretation of the Patterson map extremely difficult. However, interpretation can be 
simplified if the Patterson map has been calculated from only a few atoms. Hence, the 
Patterson map of only the heavy atoms is calculated in the MIR method. To calculate 
the Patterson map of the heavy atoms, a difference Patterson function is used. It can 
be shown that the vectors between atoms related by symmetry have one or two 
constant coordinates. Once the Patterson atoms have been obtained for the heavy 
atoms using the difference Patterson function, the real heavy atom positions in the 
unit-cell can be calculated largely by a procedure proposed by Harker, known as 






1.3.6.4 Molecular replacement 
The MIR and MAD methods are powerful techniques to obtain experimental 
phases for structure determination. However, both methods suffer from the major 
drawback of having the necessity to label the protein with heavy atoms and requiring 
more than one dataset. As more and more protein structures are being solved, another 
technique, called molecular replacement (MR), is gaining attention. MR makes use of 
the fact that if the structure of a target protein is likely to be similar to an already 
known structure, then the phases from the known structure will be a close 
approximation of the actual phases from the target structure. Proteins that share high 
degree of sequence similarity also tend to have significant structural similarity. 
Therefore, the calculated phases from a model structure can be combined with the 
measured intensities of the target protein to obtain interpretable electron density maps. 
After repeated cycles of iterative model building and refinement, the phases of the 
target structure will become more accurate.  
In order to obtain meaningful phases from the phasing model, it is required to 
orient it similar to the target protein’s orientation in the unit-cell. In the absence of the 
structure of the target protein, the correct orientation to choose is unknown. Space 
group considerations place some restrictions on the orientation of the phasing model 
inside the unit-cell of target protein. However, the number of possible orientations is 
still very large and extremely computer intensive for a brute force search. The criteria 
used for search is that the calculated structure factor intensities from the phasing 
model at a particular location should be similar to the observed structure factor 
intensities from a diffraction experiment. For a brute force approach to search for the 
best orientation, the phasing model needs to be rotated around and translated along the 
3 unit-cell axes, producing 6 parameters for optimization. Exhaustively trying 
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different values for these 6 parameters at random is an extremely computer intensive 
task as the number of possible combinations will be extremely large. However, the 
task can be made less intensive if the rotation and translational searches are performed 
separately (Rossmann and Blow, 1962). In order to enable separate searches for the 
rotation and translation of the phasing model, the Patterson function is used. The 
unique property of the Patterson function is that it is the same for a phasing model 
with the same rotation axis values, irrespective of the translation axis values. This 
implies that two models will give the same Patterson function wherever they are 
located in the unit-cell as long as they have the same rotation values. Using this 
feature of the Patterson function, the correct values for the rotation axis can be 
estimated. Once these values are known, they can be applied along with different 
values of the translational axis to calculate structure factor intensities. These 
calculated values are then matched with experimental values to arrive at optimal 
translational axis values. 
 
1.3.7 Refinement 
 The final model of a protein molecule is the result of appropriate refinement of 
an initial model. Model refinement refers to optimally fitting the atomic positions and 
temperature factors to the experimental data. In other words, the residues (or atoms) 
of the molecule are fit to electron density maps and their geometry is regularized. 
Since collecting data with Miller indices (hkl) -∞ to +∞ (where dhkl approaches 0), 
which is a pre-requisite for an error free electron density map, is impractical, a model 
is fit to electron density maps at the available resolution of the experimental data. As 
the model keeps improving during the iterative cycles of model building and 
refinement, more accurate phases are available, which, in-turn, improve the electron 
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density map. As the electron density maps improve, more accurate phases are 
generated. The overall fit between the model and the experimental data is measured 
using the R-factor, Eq. 1.13, where Fobs = experimentally determined structure factors 
and Fcalc= structure factors calculated from the target structure.    
   
               
     
              
Traditionally, least-squares (LSQ) refinement has been used for optimizing model 
parameters. However, modern refinement programs attempt to minimize maximum 
likelihood (ML) functions or the energy of the crystal system, which tend to give 


















CHAPTER 2. TRANSCRIPTIONAL REPRESSOR DOMAIN 
(TRD) OF MBD1 
 
In this part of the thesis, I present the structure and function of the 
transcriptional repressor domain (TRD) of the methylated DNA binding protein 
MBD1. The structure was determined using NMR spectroscopy and based on that, 
functional studies were undertaken to elucidate the mechanism of target recognition in 
epigenetic gene silencing. 
 
2.1  EPIGENETICS 
  Epigenetics is the study of hereditary inheritance of changes in gene function 
that happens without any change in the DNA sequence (Wolffe and Matzke 1999). 
Such modification allows the transfer of information between dividing cells, although 
such information is not present in the nucleotide sequence of the gene. For example 
when a bone cell divides, the daughter cells will express only those genes required for 
bone formation and other genes corresponding to other organ such as liver cells 
remains silent.  
Epigenetics controls the regulation of gene expression through DNA 
methylation, chromatin modification and posttranslational changes of proteins, for 
example histones and transcriptional machineries, (Fig. 2.1) (Nakao 2001). A 
transcriptionally active condition can be inferred from DNA hypomethylation, 
hyperacetylation of histones, and active chromatin. At the same time, repression of 
gene transcription occurs when there is DNA hypermethylation, deacetylation of 
histones and inactive chromatin. Furthermore, lysine 4 of histone H3 (H3K4) 
methylation is correlated with transcriptional activation while transcriptional 
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repression is marked by the methylation of lysine 9 of histone H3 (H3K9) (Fischle, 
Wang et al. 2003). Transcriptional activation is carried out by binding of transcription 
factors, which bind to specific DNA sequences and then recruit coactivators such as 
histone acetyltransferases and H3K4 methyltransferases. In the same way, methylated 
DNA-binding proteins and transcriptional repressors will recruit corepressors, such as 
histone deacetylases (HDACs) and H3K9 methyltransferases (Fig. 2.1). In addition to 
that, methylated and acetylated histone surfaces recruit additional factors, such as 
heterochromatin protein-1 (HP1), which specifically binds methyl-H3K9 (Nakao, 
Minami et al. 2004). This epigenetic mechanism is essential for normal cell division 
and differentiation, such as expression of a particular cell specific gene. In contrast to 
the normal physiological conditions, it is abnormally regulated in cancer cells (Chen, 





Figure 2.1. Epigenetics and chromatin. Gene activation marked by 
DNA hypomethylation, histone acetylation and binding of activators 
and Repression is marked by DNA methylation, histone deacetylation 
and binding of repressors (Nakao, Minami et al. 2004). 
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2.2  DNA METHYLATION 
One of the major covalent modifications of eukaryotic DNA is the methylation 
of the palindromic CpG sequence in a symmetrical manner (SINSHEIMER 1955). 
Scarano (Scarano 1971) first proposed DNA methylation Holliday and Pugh 
(Holliday and Pugh 1975) and Riggs (Riggs 1975) showed its involvement in cell 
differentiation and development. CpG rich regions, found in mammalian gene 
promoters and known as “CpG islands”, are generally unmethylated and the remaining 
70-80% of mammalian CpG sites are usually methylated (Ehrlich and Wang 1981). 
CpG islands are present in the promoter regions of all constitutively expressed genes 
(Zhu, He et al. 2008). However, not all CpG islands are non-methylated and some of 
them that are involved in X-inactivation and genomic imprinting remain methylated 
depending on cell requirement (Edwards and Ferguson-Smith 2007). DNA methyl 
transferase (DNMT1) catalyses the methylation of the naked cytosine in a hemi-
methylated CpG (Fournier, Sasai et al. 2012). This process of DNA methylation, 
resulting in gene repression, will be inherited from mother to daughter in active cells 
(Bird and Wolffe 1999; Bird 2002; Edwards and Ferguson-Smith 2007).  
 
Figure 2.2. Gene silencing due to promoter methylation. The 
promoters of tumor suppressor genes get methylated in cancer cells 
and thus transcriptional activators are unable to bind for transcribing 
the gene (Baylin 2005). 
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Aberrant DNA methylation could result in severe disorders in the cell. 
Hypomethylation could lead to inappropriate expression of genes while 
hypermethylation could result in gene repression, (Fig. 2.2) (Costello, Frühwald et al. 
2000; Esteller, Corn et al. 2001). Methylation of CpG islands occurs in various 
cancers, thereby inducing silencing of tumor suppressor genes, like Cdh1 in breast, 
bladder and prostate cancers (Graff, Herman et al. 1995), and the Rb gene in 
retinoblastomas (Stirzaker, Millar et al. 1997). This aberrant methylation generally 
occurs in cancer cells and there are ways to control this by administering DNA methyl 
transferase inhibitors such as 5-aza-2'-deoxycytidine or knock down by using 
antisense or siRNA. Results from the human colorectal cancer cell line HCT116 
confirm the re-expression of the tumor suppressor gene Cdkn2a and provide a direct 
link between the methylation of its promoter and its transcription (Fuks, Burgers et al. 
2000; Geiman, Sankpal et al. 2004). At the same time, DNMT1, DNMT3a or 
DNMT3b inhibition in a non-specific manner could result in aberrant expression of 
several genes, which are supposedly silenced in the normal cell, and could affect the 
physiological function of the cell.  
DNA methylation plays an important role in genomic imprinting, the strategy 
by which a cell controls the expression of certain genes in the genome according to 
their parent of origin (Price, van der Leij et al. 2002). Thus the DNA methylation state 
plays a critical role in the transcriptional repression of genes, chromatin structure 
organization and embryo development while aberrant DNA methylation could result 






2.3  METHYLATED CPG DNA BINDING PROTEINS  
Identification and characterization of proteins that bind to methylated DNA in 
a specific manner is of major importance. With the help of electrophoretic mobility 
shift assay (EMSA), the binding of the MeCP1 protein, an MBD family member, to 
CpG methylated DNA was observed in the nuclear extracts of a variety of mammalian 
tissues and cell lines (Meehan, Lewis et al. 1989). However, at that time it was 
difficult to differentiate the mediator of methylation dependent transcriptional 
repression (Boyes and Bird 1991). A second methyl-CpG specific binding activity for 
MeCP2, which is distinct from that of MeCP1, was found in rat brain nuclear extracts 
(Lewis, Meehan et al. 1992). Followed by deletion analysis of recombinant MeCP2, a 
minimal region that is needed for specificity towards methylated DNA was identified 
and termed as methyl-CpG binding domain or MBD (Nan, Meehan et al. 1993). 
Furthermore, searches of EST databases led to the identification of several MBD 
containing proteins.  
 
Figure 2.3. Domain Architecture of Methyl CpG Binding Proteins: 
Methylated CpG Binding Domain (MBD), Cysteine rich zing finger 
domain (CxxC), Transcriptional Repressor Domain (TRD) and DNA 
N-Glycosylase Domain are present among the family members of 
methylated CpG binding proteins (Fatemi and Wade 2006).  
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The human MBD1 gene was the first to be cloned (Cross, Meehan et al. 1997), 
followed by the MBD2, MBD3 and MBD4 genes from mouse (Hendrich and Bird 
1998). Like MeCP2, the newly identified MBD1, MBD2, and MBD4 proteins bind 
specifically to methylated CpG DNA in vitro, while MBD3 being an exception. A 
schematic diagram of the architecture of MBD proteins is shown in (Fig. 2.3).  
 
2.3.1  Structure of MBD 
The structure of MBD of MeCP2 and MBD1 was solved using nuclear 
magnetic resonance (NMR), which reveals a wedge shaped α/β-sandwich structure 
comprising of a four stranded anti-parallel β-sheet, attached to a short α-helix (Ohki, 
Shimotake et al. 1999; Wakefield, Smith et al. 1999). Later the structure of MBD 
from MBD1 was solved in complex with methylated CpG DNA using NMR (Ohki, 
Shimotake et al. 2001). Upon binding to DNA, a nine amino acid loop between the 
inner strands of the β-sheet gets structured and together with the inner β-strands and 
the loop connecting to the α-helix, this forms the majority of the interface with the 
major groove of the DNA. It was further noted from the structure that specific 
hydrophobic residues form the basis of interaction with the methyl groups on 
cytosine. However, a recent X-ray crystal structure of MBD from MeCP2, in complex 
with methylated DNA, (Fig. 2.4) shows that instead of hydrophobic contacts between 
methyl group, the water molecules are positioned around methyl groups make contact 
with the hydrophilic residues of MBD (Mayer-Jung, Moras et al. 1998; Ho, McNae et 
al. 2008). 
 
2.3.2  MECP2 
  MeCP2 is a 53 kDa protein, which binds to methyl-CpG pairs (Lewis, Meehan 
et al. 1992) and a flanking run of four or more A/T base pairs enhances the affinity 
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(Klose and Bird 2004). Expression of the MeCP2 protein level varies depending on 
cell type with the rat brain having the highest, followed by kidney, spleen, liver and 
the lowest in testes (Nan, Meehan et al. 1993). Inside the nucleus, once MeCP2 binds 
to methylated CpG, it initiates transcriptional repression by recruiting the co-repressor 
molecules such as Sin3 and histone deacetylase (HDAC) to form a complex (Nan, Ng 
et al. 1998; Ng, Zhang et al. 1999). MeCP2 binds to HDAC through its transcriptional 
repression domain, residues 207-310 (Yu, Thiesen et al. 2000).  
 
Figure 2.4. Crystal Structure of MBD of MeCP2 in complex with 
methylated DNA: From the structure, it can be inferred that methyl 
group in cytosine of DNA will recruit water and which in turn make 
contacts with hydrophilic residues such as Arg and Asp of MBD (a) 
Methylated CpG DNA nucleotide sequence, (b) Complex structure of 
MeCp2-MBD with methylated DNA, (c) Overlay of native NMR 
structure with the complex structure of MeCp2-MBD, (d) Non bonded 
contacts with DNA, (e) Hydrogen bonding contacts with DNA (Ho, 




When cells were treated with trichostatin A (an inhibitor of HDAC), they do 
not fully recover from transcriptional repression which confirms that MeCP2 does not 
totally depend on HDAC for repression and also it acts through other repressor 
complexes (Yu, Thiesen et al. 2000). MeCP2 was also found to be mutated at specific 
residues in Rett’s syndrome and MeCP2 null mice showed abnormal behavior with 
loss of cognitive function, which confirms that MeCP2 has important role in neuronal 
function (Chahrour, Jung et al. 2008).  
 
2.3.3  MBD2 
MBD2 was first identified by Hendrich and Bird (Hendrich and Bird 1998) by 
searching for putative MBD domains in EST databases. It can be classified to MBD2a 
and MBD2b, where MBD2b lacks a glycine rich region of MBD2a. MBD2 might 
function as a histone deacetylase and chromatin remodeling transcriptional repressor 
based on reporter assays (Ng, Zhang et al. 1999; Feng and Zhang 2001). In addition, 
in vitro analysis proved that MBD2 hastens the binding of the NuRD complex to 
methylated DNA in nucleosomes, which are then remodeled and deacetylated. These 
findings also gave an idea that MBD2 and MBD3 might co-exist in the same NuRD 
complex, but another study showed the presence of distinct MBD2- and MBD3-
containing NuRD complexes (Le Guezennec, Vermeulen et al. 2006). Mbd2 also 
seems to be needed in the colon to repress genes that are normally expressed in the 
exocrine pancreas (Berger, Sansom et al. 2007). Furthermore, the Xist gene promoter 
is also directly repressed by Mbd2 is (Barr, Hermann et al. 2007). In the above cases 
Mbd2 is found to represses transcription by recruiting histone deacetylase to 




2.3.4  MBD3 
MBD3 is a 265 amino acids (32 kDa) protein with an N-terminal MBD 
domain and a C-terminus region rich in acidic residues. MBD3 does not bind to 
methylated DNA, even though it has the MBD domain (Hendrich and Bird 1998). But 
unlike the human one, Xenopus laevis xMBD3 binds to methyl-CpG (Wade, Gegonne 
et al. 1999). xMBD3 is expressed profusely in the early stages of development in eye, 
brain and bronchial arches. MBD3 was also found to co-purify with the Mi-2/NuRD 
complex (Le Guezennec, Vermeulen et al. 2006). The highly conserved MBD domain 
of MBD3 could also have a important role in protein-protein interactions. 
 
2.3.5  MBD4 
MBD4 is a 62.6 kDa protein and has a conserved MBD domain at the N-
terminus and a typical glycosylase domain at the C-terminus involved in DNA repair 
(Hendrich and Bird 1998). The MBD domain of MBD4 binds to symmetrically 
methylated DNA and the C-terminal DNA glycosylase catalytic domain is a thymine 
and uracil glycosylase specific for G-T and G-U mismatches. MBD4 was found to 
suppress tumorigenesis by preventing CpG mutability, i.e. CpG to TpG mutation, and 
thus MBD4 deficient mice are much prone to tumor (Millar, Guy et al. 2002). 
 
2.3.6  MBD1 
MBD1 is a 63 kDa protein and comprises of a highly conserved MBD domain, 
which binds to symmetrically methylated DNA at the N-terminus, a cysteine rich 
CXXC zing finger domain that binds unmethylated DNA and a number of CXXC 
domain, whose number varies upon isoforms and a transcriptional repressor domain 
(TRD), which is capable of forming an effective repressor complex by recruiting a co-
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repressor complex (Ng, Jeppesen et al. 2000; Nakao, Matsui et al. 2001). The first 
human isoform, designated as PCM1, and an antibody raised against MBD1 was seen 
to ‘supershift’ the MeCP1 activity in EMSA and it was earlier thought that MBD1 
might be a component of the MeCP1 complex (Cross, Meehan et al. 1997). However, 
later studies showed that there was cross reactivity of the MBD1 antibody with the 
MeCP1 complex (Ng, Zhang et al. 1999; Ng, Jeppesen et al. 2000). Full-length 
recombinant human MBD1 (PCM1) binds methylated DNA and suppresses 
transcription in a methylation dependent manner in vitro (Cross, Meehan et al. 1997). 
Recombinant mouse MBD1 was also able to bind to methylated DNA in vitro 
(Hendrich and Bird 1998). MBD1 was able to repress transcription on transfected 
reporter genes when transiently expressed in mammalian cells (Fujita, Takebayashi et 
al. 1999). Both isoforms MBD1v1 and MBD1v2 are able to repress transcription 
irrespective of whether it was a methylated or unmethylated promoter and repression 
of unmethylated reporters totally depends on the presence of the zinc finger domain 
CxxC3 in MBD1 (Fujita, Shimotake et al. 2000). In addition to this earlier study, an 
isolated CxxC3 domain from mouse Mbd1 binds to unmethylated CpG containing 
DNA in a specific manner (Jørgensen, Ben-Porath et al. 2004). The localization of 
over expressed MBD1 to mouse pericentric heterochromatin depends upon the 
presence of wild type MBD and the presence of CXXC3 in the case of methylation 
deficient mice. The importance of MBD1 in neuronal cell differentiation has been 
reported. Mice deficient in MBD1 showed impairment in adult neurogenesis and 
differentiation of neural stem/progenitor cells (NSPCs), due to the over expression of 
fibroblast growth factor 2 (FGF2), which normally prevents neural cell differentiation 
(Zhao, Ueba et al. 2003; Li, Barkho et al. 2008). The importance of this epigenetic 
mechanism regulating the differentiation of NPSCs could be further understood from 
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another study, where MBD1 plays a major role in normal maintenance of neuronal 
cell differentiation. MBD1 was identified to be involved in the repression of miR-184 
expression in neuronal cells, whereas miR-184 prevents the expression of Numbl, 
which is responsible for differentiation of NSPCs. It could be understood that it forms 
a signaling network between MBD1, miR-184 and Numbl (Liu, Teng et al. 2010).  
From these above studies, we could understand the importance of MBD1 in 
neuronal cell regulation by regulating the epigenetic machinery inside cells. At the 
same time the level of MBD1 expression is found to be high in pancreatic cancer cell, 
which lowers the level of tumor suppressor gene expression. This effect can be 
reversed by inhibiting MBD1 expression (Xu, Liu et al. 2008). In all we could 
understand that MBD1 has high importance in physiological cell regulation and its 
over expression might results in cancer, where it silences several tumor suppressors. 
Thus it is clear that there should be a balance in the level of MBD1 in cells. The 
functional importance and roles of the MBD, CXXC and TRD domains of MBD1 in 
the regulation of gene expression are discussed in detail in the following sections. 
 
2.3.6.1 DNA binding domain 
MBD1 has two DNA binding domains, of which MBD binds specifically to 
methylated CpG and the CXXC3 domain binds to unmethylated CpG (Jørgensen, Ben-
Porath et al. 2004). The structure of MBD of MBD1, in complex with methylated 
DNA, was solved using the NMR technique (Ohki, Shimotake et al. 2001) and there 
is a continuous patch of hydrophobic residues that makes contact with the methylated 
DNA, Fig. 2.5a. Also the structure of Myeloid/Lymphoid or Mixed-Lineage, 
Leukemia (MLL) and CXXC finger protein 1 (CFP1) CXXC domain in complex with 
unmethylated DNA which is highly homologous to the human MBD1 CXXC3 
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domain was solved using NMR and X-ray crystallography, respectively (Cierpicki, 
Risner et al. 2010; Xu, Bian et al. 2011). From the structures it is inferred that charged 
residues Arg and Lys are more important for recognizing unmethylated CpGs (Figs. 
2.5 b, c).  
       
 
Figure 2.5. Known structures of MBD1.(a) NMR Structure of MBD 
of MBD1 in complex with methylated DNA (Ohki, Shimotake et al. 
2001) (b) The CXXC domain in complex with unmethylated CpG: The 
crystal structure of CXXC of CFP1 in complex with DNA (Xu, Bian et 
al. 2011) and (c) The NMR structure of CXXC of MLL in complex 




The structure of the DNA binding domain of MBD1 gives us a clear idea on 
the specificity of the DNA binding domain towards methylated and umethylated CpG. 
These domains are of high importance in cell signaling, such as heterochromatin 
formation and selective expression of certain genes on an organ specific manner. The 
presence of the unmethylated CpG DNA binding domain CXXC3 of MBD1 could 
repress any gene expression once it binds to a promoter and recruits repressor 
complex proteins, but still the function of CXXC3 of MBD1 in cell signaling is 
unclear as promoters in the human genome contain unmethylated CpG island.  
 
2.3.6.2 Transcriptional Repressor Domain (TRD)  
The human MBD1 variant PCM1 was found to repress transcription of 
transfected reporter genes when fused to a heterologous DNA binding domain and 
this allowed the mapping of a transcriptional repression domain (TRD) to the C-
terminus of MBD1 (Ng, Jeppesen et al. 2000). TRD is about 64 amino acids long and 
acidic in nature with pI of 4.2. The ability of TRD to repress the expression of a 
transfected reporter gene has been reported (Ng, Jeppesen et al. 2000). When TRD is 
fused to a heterologous DNA binding domain, such as GAL4 DNA binding domain at 
the N-terminus, which binds to the reporter gene promoter, TRD recruits co-repressor 
complex proteins that are required for transcriptional repression. While TRD recruits 
HDAC proteins to repress gene expression, when treated with HDAC inhibitor, 




Figure 2.6. Repressor Activity of TRD. TRD was able to repress the 
reporter gene even at distance from transcription starter site when 
fused to GAL4 DNA binding domain and also the activity of TRD was 
reduced when treated with HDAC inhibitor (Ng, Jeppesen et al. 2000). 
 
 
These finding confirms that TRD might be acting through other pathways that 
are involved in heterochromatin formation. It was later identified that TRD recruits 
binding partners such as the MCAF1 family of proteins and in turn recruits the 
SETDB1 complex to form an effective repressor system (Fujita, Watanabe et al. 2003; 
Ichimura, Watanabe et al. 2005). 
 
2.3.6.3 MBD1 interacts with MCAF/AM family proteins through TRD to form 
heterochromatin 
MBD1 containing chromatin association factor 1 (MCAF1) acts as an 
activator of transcription, when it binds to Specificity Protein 1 (Sp1) and then it 
recruits ATFa transcription factors involved in activation of various gene expression 
(Courey, Holtzman et al. 1989). MBD1, through its TRD region, is shown to interact 
with the C-terminus of MCAF1 (residues 1154 to 1270) (Fujita, Watanabe et al. 2003) 
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and in a similar manner, the homologous protein MCAF2 also interacts with MBD1 
(Ichimura, Watanabe et al. 2005). Furthermore, selected hydrophobic residues of TRD 
are shown to be essential for interaction with MCAF/AM proteins, (Fig. 2.7).  
 
Figure 2.7. MBD1 Interaction with MCAF1 via TRD. Hydrophobic 
residues of MBD1 belongs to TRD region i.e. I576 and L579 are 
essential for binding to MCAF1 (Ichimura, Watanabe et al. 2005).  
 
Thus MBD1 binds to MCAF1 and prevents its interaction with Sp1 and causes 
transcriptional repression. MBD1 interaction with MCAF1 will further recruit the 
SETDB1 complex to form a strong heterochromatin complex (Fujita, Watanabe et al. 
2003). SETDB1 mediates the methylation of histone at lysine residues resulting in 
chromatin remodeling to form a compact mass and does not facilitate the binding of 
transcription factors to initiate gene expression. Thus it can be understood that MBD1 
mediated transcriptional repression is majorly through MCAF1 binding rather than 
HDAC activity itself. Another related study showed that sumoylation of TRD will 
enhance the binding of MCAF1 to MBD1, which in turn helps in strong 
heterochromatin formation (Uchimura, Ichimura et al. 2006). Once it forms a 
heterochromatin complex, it could repress the gene expression of transfected reporter 
genes. In fact, the presence of TRD alone is enough to cause repression of a gene 
since it interacts with the repression complex machinery by itself, and the only 
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requirement is the presence of the DNA binding domain to repress any gene promoter, 
Fig. 2.8. Thus TRD is very important as a highly active repressor domain and its 
mode of partner recognition is also of high importance. 
a      b  
 
Figure 2.8. Heterochromatin formation by MBD1. (a) GAL4-TRD 
able to repress the reporter gene expression in the presence of MCAF1 
and SETDB1, where clear repression occurs in the case of Sp1 
mediated expression (b) MBD1 forms heterochromatin complex with 
MCAF and SETDB1 (Ichimura, Watanabe et al. 2005)  
 
2.3.6.4 MBD1 is required for PML-RARα mediated gene repression where TRD is 
essential for co-repression 
PML-RARα is an oncoprotein which blocks hematopoietic differentiation and 
results in acute promyelocytic leukemia (APL). It generally functions through the 
repression of proteins involved in differentiation of blood cells, such as RARβ2, by 
repressing RARE genes (Lin, Nagy et al. 1998). PML-RARα forms a strong repressor 
complex with DNA methyl transferases and HDAC3, and interestingly MBD1 is also 
part of the complex. PML-RARα recruits MBD1 through HDAC3, since MBD1 
directly interacts with HDAC3 through the TRD. PML-RARα facilitates the 
methylation of DNA by recruiting Dnmt1 and then HDAC3, which is part of N-CoR 
complex, also will be present in contact with PML-RARα and in turn MBD1 will be 
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recruited to that methylated promoter region, thus further transcription of that 
particular gene will be affected, resulting in gene silencing. HDAC3 was found to 
interact with the TRD region of MBD1 through hydrophobic interaction, since 
mutants in that region fail to interact with HDAC3. Most importantly, TRD is needed 
to repress gene expression in acute myeloid leukemia (Villa, Morey et al. 2006). A 
schematic model of the PML-RARα repressor complex and the associated molecular 




Figure 2.9. PML-RARα forms Co-Repressor with MBD1 and 
HDAC3. (a) Co-IP experiment confirms that the PML-RARα exists as 
complex with HDAC3 and MBD1 in APL cells (b) Schematic 
representation of PML-RARα co-repressor complex with N-CoR, 
HDAC3 and MBD1 (Villa, Morey et al. 2006). 
 
2.3.6.5 MBD1 interaction with MPG occurs through TRD  
3-methyl purine DNA glycosylase (MPG) is involved in a DNA repair 
mechanism. When there is any damage in DNA base pairs adenine or guanine, due to 
alkylation, deamination or oxidation, it binds to such a modified base and cleaves of 




followed by endonuclease removal of that base, replacement with an intact base and 
ligation (Wyatt, Allan et al. 1999). MPG is an important enzyme in DNA repair, since 
MPG knock down mice showed high sensitivity to alkylation damage (Engelward, 
Weeda et al. 1997). MPG was found to be present in the MBD1 complex and yeast 
two hybrid screen performed with TRD as a bait showed that MPG interacts with it in 
a specific manner and fails to interact with CXXC or MBD of MBD1. Full length 
MPG was found to be essential for interaction with TRD of MBD1, since truncations 
at the N-terminus or C-terminus affected the interaction and co-localization inside 
mammalian cells. It was presumed that MPG could be a part of the heterochromatin 
complex with MBD1 and indeed the presence of MPG enhanced gene repression by 
MBD1. In other words, MBD1 is essential for effective DNA repair by MPG, since 
the cells that lack MBD1 are unable to carry out DNA repair effectively unlike in the 
presence of MBD1 (Watanabe, Ichimura et al. 2003). 
The above studies confirm that the interaction between MBD1 and MPG is 
essential for effective DNA repair and heterochromatin formation, and such 
interaction is mediated through TRD of MBD1, (Fig. 2.10). 
 
Figure 2.10. MBD1 interaction with MPG via TRD. GST pull-down 
and co-localization experiment confirms the presence of FL MPG is 







1. To determine the structural features of TRD of MBD1 using NMR. 
2. To determine the mode of interaction of TRD with its binding partners such  
    as MPG and MCAF1Δ8, using NMR, ITC, etc. 
3. To determine the importance of specific residues involved in interaction  
between TRD and its binding partners, by carrying out site-directed 
mutation      based on the biophysical studies and verified using in vitro and 






















CHAPTER 3. MATERIALS AND METHODS 
 
3.1 SUBCLONING FOR PROTEIN EXPRESSION 
 The gene fragment encoding residues 507-605 of MBD1, including the 
transcription repressor domain (TRD, residues 529-592) was PCR amplified using the 
Pfu DNA polymerase (Fermentas) with the forward primer 
ATTGAATTCGACGAGTGGACACCAGand reverse primer 
TATCTCGAGCTACTGCTTTCTAGCTC (1
st
 Base), containing the EcoRI and the 
XhoI restriction sites (underlined), respectively. The gene fragment was subcloned 
into the pET-M (pET32a modified) vector with an N-terminal His tag and pGEX6P-1 
vector with an N-terminus GST tag for protein expression and purification. In the case 
of MPG, the full length gene of MPG was amplified with a forward primer containing 
an EcoRI site (ATTGAATTCATGCCCGCGCGCAGC) and a reverse primer with an 
XhoI site (TTACTCGAGTCAGGCCTGTGTGTCCTGC)and then subcloned into the 
pETM vector. The gene encoding for the MCAF1 residues 1154-1270 that interact 
with TRD, hereafter named as MCAF1Δ8, was amplified with the forward primer 
ATTGAATTCGAAGCTGCCAGCACATCTCTGCCTC (with an EcoRI site) and the 
reverse primer ATTGCGGCCGCTTAACTGCTCTGGGTAGAAGAG (with a NotI 
site) and then subcloned into the multiple cloning site 1 (MCS1) of the pETduet-1 
vector with an N-terminal MBP tag and the pET-M vector with an N-terminal His-tag 
for protein expression. 
 
3.2  PROTEIN EXPRESSION AND PURIFICATION 
 Seed cultures of transformed E. coli BL21 (DE3) (Stratagene) competent cells 
were added to large-scaled LB medium containing 100 μg/ml ampicillin (Gold 
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Biotech). Cells were grown until A600 nm was 0.6 to 0.7 before adding 0.15 mM 
isopropyl-1-thio-β-D (-) thiogalactopyranoside (IPTG) (Gold Biotech) for protein 
over-expression for another 14 to 18 h at 16 °C. Cells were harvested and the pellet 










C isotopic glucose (Cambridge Isotopes) or 
12
C glucose. 
The cell pellet was resuspended in binding buffer A: 50 mM Tris-HCl buffer, 
150 mM NaCl, 2mM DTT, 5% Glycerol, 0.1% Triton X-100 with final pH adjusted to 
7.0. The cell suspension was lysed by sonication on ice and the supernatant was 
loaded onto an Ni-NTA column and subsequently allowed to bind for 1 h at 4 °C. 
Weakly bound proteins were removed by extensive washing using binding buffer A 
and buffer B (buffer A with 10 mM imidazole). TRD was finally eluted with buffer B 
containing 300 mM imidazole. The eluted TRD was loaded to a Superdex 75 column 
(GE Healthcare) equilibrated with 20 mM sodium phosphate, 50 mM NaCl and 3 mM 
DTT, pH adjusted to 6.5. TRD eluted as a single homogenous peak, but at a different 
molecular weight (corresponding to 44 kDa instead of its 12 kDa), probably due to its 
intrinsic disorderliness. The same steps of purification was followed for unlabelled, 
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C double labeled TRD. The purified protein was concentrated 
to 10 mg/ml using ultra 3 kDa Mol. Wt. cut off Centricon (Merck Millipore). 
Expression of pGEX-6P-1:TRD followed almost the same above conditions, 
but during purification, the lysate was allowed to bind to glutathione sepharose beads 
(GE Healthcare), equilibrated with buffer A for 3 h at 4 °C, then washed with Buffer 
A for 3 times. The GST tag was removed from TRD using 1 unit of Prescission 
protease per mg of GST-TRD at 4 °C. The cleaved TRD protein was loaded to a 
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Superdex 75 column (GE Healthcare), equilibrated with the same elution buffer as 
before and concentrated. 
MPG was over-expressed with an N-terminal 6xHis tag in the pET-M vector. 
In short, the construct was transformed into E. coli BL21 (DE3) competent cells and 
the protein was over expressed and first affinity purified using Ni-NTA resin. The 
protein was further purified using a cation exchange Hi-Trap SP-HP (GE Healthcare) 
column (MPG is highly basic with pI of about 10), with buffer A: 20 mM sodium 
phosphate and buffer B: 20 mM sodium phosphate, 1 M NaCl pH adjusted to 8.0. 
MPG was again purified using a Superdex 75 column (GE Healthcare) equilibrated 
with 20 mM sodium phosphate, 50 mM NaCl and 3 mM DTT, pH adjusted to 6.5. 
The protein eluted as a single homogenous peak, at its theoretical Mol. Wt. of 35 kDa. 
The purified MPG protein was concentrated using ultra filtration membrane (Merck 
Millipore) with 10 kDa Mol. Wt. cut off. 
 MCAF1Δ8 was over-expressed using the pETduet-1 vector as an N-terminal 
MBP-fusion protein. Seed cultures of transformed E. coli BL21 (DE3) competent 
cells were added to large scale LB medium containing 100 μg/ml ampicillin. The cell 
density was monitored until A600nm was 0.6 to 0.7, before adding 0.1 mM IPTG for 
protein over-expression for another 16 h at 18 °C. Cells were harvested and cell pellet 
was stored at -80 °C until needed. The cell pellet was resuspended in binding buffer 
A: 50 mM Tris-HCl buffer, 150 mM NaCl, 2 mM DTT, 5% Glycerol, 0.1% Triton X-
100 and final pH adjusted to 8.0. The cell suspension was lysed by sonication on ice 
and the supernatant was loaded onto an amylose (NEB) column and subsequently 
allowed to bind for 2 h at 4 °C. The weakly bound proteins were removed by 
extensive washing using binding buffer A for 3 to 4 times. The MBP: MCAF1Δ8 
fusion protein was eluted with 20 mM maltose in buffer A. Thus purified MBP-
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MCAF1Δ8 was passed through a Superdex 200 column (GE Healthcare) equilibrated 
with 20 mM sodium phosphate, 50 mM NaCl and 3 mM DTT, pH adjusted to 6.5. 
MBP: MCAF1Δ8 eluted as a single homogenous peak, at its theoretical Mol. Wt. of 
55 kDa. The purified protein was concentrated using ultra filtration membrane (Merck 
Millipore) with 10 kDa Mol. Wt. cut off. The MBP tag was not cleaved, as 
MCAF1Δ8 by itself is very unstable and precipitates immediately after purification. 
Table 3.1 List of Constructs used in this study of TRD 
S. 
No 











































3.3  CIRCULAR DICHROISM SPECTROSCOPY 
Circular dichroism (CD) spectroscopy experiments were performed on a 
JASCO J-810 spectropolarimeter. A quartz cuvette with 1.0 mm optical path was 
filled with 200 μl proteins (~ 25 μM) in 10 mM NaH2PO4/ Na2HPO4, pH 6.5 and 




3.4  ISOTHERMAL TITRATION CALORIMETRY (ITC)  
The interaction of TRD with MPG and MBP: MCAF1Δ8 was verified using a 
VP-ITC microcalorimeter (MicroCal) at 25 °C in 20 mM NaH2PO4/ Na2HPO4 
buffer, pH 6.5. The cell contained 50 μM MPG or 20μM MBP: MCAF1Δ8. The 
syringe contained 500 μM of TRD against MPG and 200μM of TRD against 
MCAF1Δ8, was prepared in the same buffer. Samples were first degassed for 15 min 
and titration was performed using a stirring speed of 390 rpm. The initial injection for 
TRD was 2 μl for 10 s and subsequent injections were 10 μl for 10 s with 240 s 
spacing. Data points were fitted using the integrated program ORIGIN (MicroCal) for 
one-site binding. 
 
3.5  DYNAMIC LIGHT SCATTERING (DLS) 
Dynamic light scattering measurements were performed at room temperature 
on a DynaPro (Protein Solutions) DLS instrument. The homogeneity of the protein 
samples was monitored at various stages of concentration in order to avoid 
aggregation. The percentage of polydispersity was below 16% and the SOS error was 
less than 50 for all protein samples at various concentrations. 
 
3.6  GST PULL-DOWN ASSAY 
For GST pull down assay, about 1 μg of GST alone and GST-fused TRD wild 
type and TRD mutants was allowed to bind to glutathione sepharose beads (GE 
Healthcare) in buffer containing 50 mM Tris-HCl buffer, 150 mM NaCl, 2 mM DTT, 
5% Glycerol, 0.1% Triton X-100, pH 7.0. MBP:MCAF1Δ8 and 6xHis:MPG were 
also prepared with the same buffer and equal amount of proteins was allowed to bind 
to GST:TRD and mutants. The beads were washed with buffer alone for three times. 
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Finally complexes were eluted with 20 mM reduced glutathione and western blotted 
using anti-His antibody. 
 
3.7  NMR DATA ACQUISITION AND ANALYSIS 
All NMR experiments were performed on a 500 or 800 MHz NMR 












C HSQC, 3D 





N edited-NOESY (Xu, Long et al. 2007). 
  All data were processed with NMRpipe and analyzed with NMRview or in-
house NMRspy and an extension XYZ4D (http://yangdw.science.nus.edu.sg/Software 
&Scripts/XYZ4D/index.htm). NMRspy was recently developed to facilitate resonance 
assignment with the 4D NOESY-based strategy (Xu, Zheng et al. 2006).  
 
3.7.1 Δ(Cα-Cβ) combined chemical shift plot  
Δ(Cα-Cβ) combined chemical shift plot based on (Cα, TRD - Cα, random coil) - 
(Cβ, TRD - Cβ, random coil) was used to identify well-defined secondary structure, 
where continuous positive values (> 3 ppm) represent the α-helix region and 
continuous negative values (< -2 ppm) represent β-sheet region. Random coil values 
are obtained from the averaged shift values of each amino acid available at the 
Biological Magnetic Resonance Data Bank (BMRB).  
 
3.7.2 Corrected residual chemical shift plot  
To identify possible residual secondary structure, a corrected residual 
chemical shift plot was used. Unlike the Δ(Cα - Cβ) combined chemical shift plot, the 
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corrected residue chemical shift plot takes into account the nearest neighbor effect up 
to two residues away. ΔHα is calculated based on (Hα, TRD - Hα, random coil), where 
the random coil values take the random coil shifts reported for the Ac-GGXPGG-NH2 
peptide if the preceding residue (X+1) is a proline and Ac-GGXAGG-NH2 peptide if 
the preceding residue is not a proline. The correction factors A, B C, D are then 
added, where A and D account for long range effect due to X-2 and X+2 residues 
particularly if they are aromatic residues, respectively. The same is applied for ΔCα 
using equation 3.1  
ΔR(corrected) = (R - Rrandom coil) + A + B + C + D      (3.1)  
where R is Hα or Cα of a residue and four correction factors (A, B, C, D) are obtained 
from the study by (Schwarzinger, Kroon et al. 2001).  
 
3.8  STRUCTURE CALCULATION  

















N-edited subspectra) using 
NMRview or NMRspy. Backbone torsional angle restraints, Φ and Ψ were obtained 
from chemical shift data using TALOS (Cornilescu, Delaglio et al. 1999). Ambiguous 
NOEs were assigned with the iterative structure calculation method using Cyana 2.1 
(Herrmann, Güntert et al. 2002). The final 10 lowest energy structures out of 100 
calculated were selected. The quality of the structure was assessed using PROCHECK 
(Morris, MacArthur et al. 1992). All data were processed using NMRPipe program 






3.9  NMR TITRATION 




N HSQC-TROSY, an initial concentrated 
unlabeled MPG/ MBP-MCAF/ MBP was minimally added to 0.2 mM 
15
N-labeled 
TRD with the His-tag removed until a final molar ratio [MBP-MCAF/ MCAF/ 




N chemical shift difference, before and after 






   (3.2)           




N chemical shifts of an 
amide in the free and bound TRD. For intensity analysis, the ratio of the bound to the 
free TRD was derived from the ratio of the peak heights extracted using NMRspy and 
















CHAPTER 4. RESULTS 
 
4.1  EXPRESSION, PURIFICATION AND CHARACTERIZATION OF 
TRD 
 The transcriptional repressor domain (TRD) of MBD1, present at the C-
terminus, residues (507 to 605), was cloned into the pET-M vector and over expressed 
in BL21 (DE3) cells. The over-expressed protein was purified by two step 
purification, first with Ni-NTA purification and then by size exclusion 
chromatography, where it eluted as a single peak, corresponding to 45 kDa (Ziemer, 
Mason et al. 1982), instead of 12 kDa (Fig. 4.1). The fractions were verified by SDS-
PAGE, (Fig. 4.2). 
 




















       Marker        Fractions under Peak E1-E15 
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The molecular weight obtained from SDS PAGE seems to be higher than 12 
kDa and then mass spectrometry was performed to confirm the molecular weight is 12 
kDa for TRD (Fig. 4.3). And the higher molecular weight obtained in size exclusion 
could be due to non-globular nature of the protein. 
 
Figure 4.3. Molecular weight determination of TRD using mass 
spectrometry. The molecular weight was determined as 12 kDa  
 
The TRD protein was concentrated to 10 mg/ml and its homogeneity was analyzed 
using dynamic light scattering (DLS). The results confirm that TRD is homogenous 
with a polydispersity index of 9% (limit is 20%), radius 4.48 nm and SOS error 12.8 
(limit is 50), (Fig. 4.4). 
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Figure 4.4. DLS of TRD at 10mg/ml. 
 
4.3  STRUCTURAL CHARACTERIZATION OF TRD 
4.3.1  Back bone assignment using 2D 
15
N HSQC NMR 
 TRD was concentrated to 10 mg/ml for structure determination using NMR. 
The TRD protein was labeled with 
15
N for detection in Heteronuclear Single Quantum 
Coherence (HSQC), where amide peaks can be visualized, so that the number of 
peaks corresponds to the number of amino acids of the protein excluding proline, 
which has an imide instead of an amide bond and cannot be seen in HSQC. HSQC 
will give us preliminary information about the structural contents of a protein, and if a 
protein is structured with defined secondary structures then we would be able to see 
well dispersed peaks and it will be easy to differentiate them. If there is no defined 
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structure or minimal secondary structure, it will lead to narrow dispersion of peaks 
and some peaks could remain overlapped.  
 In the 2D 
15
N-HSQC, the narrow dispersion of the peaks between 
1
H: 7.6 - 8.7 
ppm hinted an overall degree of unfolded state. Although TRD is highly unstructured, 
the buffer condition was optimized to obtain well resolved 
15





N ppm window, (Fig. 4.5). This is atypical of an unstructured 
protein, which is often characterized by peak overcrowding in 
15
N-HSQC spectrum. 




N, and data were collected. Based on the fact that the chemical shift of each amino 
acid is unique, each peak was assigned, based on chemical shift and also from the 
information of neighboring amino acids in the structure in the Fig 4.5. 
 
Figure 4.5. Backbone Assignment of TRD of MBD1. The HSQC 
spectra of TRD showing the assigned residues in the region between 
1
H: 8.0-8.2 ppm and 
15
N: 121.0-123.3 ppm. Residues belonging to the 
6xHis-tag are italicized and those of MBD1 are in bold. The residues 




 To check further on whether TRD has any residual secondary structure, 
circular dichroism (CD) experiments were performed. From the CD data, (Fig. 4.6), it 
is clear that TRD by itself may not have any defined secondary structure, since there 
are no peaks between 190 and 260 nm, the specific wavelengths at which absorption 
peaks are produced by α-helices and β-strands. However, significant secondary 
structure formation is observed in the presence of 40% trifluoroethanol (TFE), an 
alpha helical inducer. 
 
 
Figure 4.6. CD Spectra for TRD. TRD by itself does not have 
secondary structures and 40% TFE induces secondary structures. 
 
4.3.2 NMR characterization of TRD 
 TRD of MBD1 is conserved in closely related organisms, where sequence 
identity is more than 50%, (Fig 4.7). TRD was known for its importance in 
transcriptional gene silencing through recruiting binding partners to the promoter of 




Figure 4.7. Multiple Sequence Alignment of TRD of MBD1 from 
closely related organisms. The charged residues and hydrophobic 
residues are highly conserved. 
 
The collected 4D data showed only a few medium and long range NOEs, suggesting 
the lack of a global fold, (Fig. 4.8a). Even though the standard chemical shift index 
for individual amino acids (based on the BioMagResBank) also suggested the absence 
of a well defined secondary structure, some residual helical structure may exist in the 
protein sequence, (Fig. 4.8 b-d). The initial Δ(C-Cβ) suggests a possible short helical 
structure between K552 and A556 despite a random coil circular dichroism profile. 
To further validate this, both C and H resonance assignments of TRD were used to 
probe for residual secondary structure as previously developed (Wishart, Bigam et al. 
1995; Schwarzinger, Kroon et al. 2001). In the region between K552 and A556, a 
contiguous stretch of residual ΔC’/H’ values are in the range of -0.25 to +1, (Fig. 
4.8 c and d), suggesting a transient helical structure. The value for properly formed 
helical or extended structures is -1 and +1. This residual helical propensity in 
unstructured TRD is further shown by the presence of dips at 205 nm and 222 nm, 
upon adding 20 to 40% TFE, a known helical inducer, (Fig 4.6). Nonetheless, the 
protein is overall highly unstructured, implying that the vital transcriptional repressor 




Figure 4.8. NMR analysis of TRD. (a) Lowest energy structure of 
MBD1Δ showing putative residual helix α’ in red. (b) Traditional 
chemical shift index (CSI) plot based on (Cα, TRD - Cα, random coil – Cβ, TRD 
- Cβ, random coil). (c) Residual CSI plot of Cα’ based on corrected random 
coil values of Cα (d) Residual CSI plot of Hα’ based on corrected 
random coil values of Hα. The putative residual helix α’ is shown 
above in (c) and (d).  
 
4.4  TRD INTERACTS WITH MPG AND MCAF1Δ8 
4.4.1  Expression and purification of MPG 
 Full length MPG (1-298 amino acids) was overexpressed in BL21 (DE3) cells 
under the T7 promoter in the pET-M vector. The overexpressed protein was purified 
in three steps: affinity purification using Ni-NTA resin, cation exchange 
chromatography (the pI of MPG is 10) and size exclusion chromatography, (Fig. 4.9). 
The MPG protein eluted as a monomer in the size exclusion chromatography, 
corresponding to its molecular weight of 35 kDa. The eluted fractions of gel filtration 





4.9. Purification of MPG. (a) Cation exchange chromatography of 
MPG (b) Size exclusion chromatography of MPG (c) 12% SDS-PAGE 
gel for the eluted fractions of size exclusion. 
 
 
4.4.2  Expression and purification of MCAF1Δ8. 
 MCAF1Δ8 (1154-1270) , fused with MBP at the N-terminus in a pET Duet-1 
modified vector and with a 6xHis tag at the N-terminus in the pET-M vector, was 
expressed in BL21 (DE3) cells. The MBP tagged protein was purified in two steps, 
affinity purification using amylose and size exclusion, (Fig. 4.10). The protein eluted 







MPG ~ 35 kDa 
Marker        Fractions under peak D13-E1 
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a       b 
 
Figure 4.10. Purification of MCAF1Δ8 with n-terminal MBP. (a) 
Size exclusion chromatography (b) 12% SDS-PAGE of elution 
fractions. 
 
 MCAF1Δ8 with an N-terminal His tag was purified in two steps: Ni-NTA 
affinity purification and size exclusion chromatography, (Fig. 4.11). The protein 
eluted as a monomer, corresponding to its molecular weight 15 kDa, in gel filtration 









Figure 4.11. Purification of MCAF1Δ8 with N-terminal 6x His tag. 
(a) MCAF1Δ8 eluted as monomer in size exclusion (b) SDS-PAGE 
shows the protein is highly pure.  
 
4.4.3  HSQC titration for TRD interaction with MCAF1Δ8 and MPG  
 MBD1 is known to interact with MCAF and MPG through its TRD. We added 
unlabeled MBP:MCAF, MBP:MCAF1Δ8 or MBP alone (as a control) to 15N labeled 
TRD at molar ratios of 1:0 to 1:3. The combined chemical shift perturbation and peak 
intensities of the residues were plotted. As there was negligible peak shift (< 0.03 
ppm), even at excess 1:3 molar ratio, (Fig. 4.12), the intensity ratio per residue for 
bound to free TRD was analyzed. Now, apart from an overall loss in peak intensities 
across the protein sequence, a continuous region of residues between Thr574 and 
Ser597 disappeared which coincides within the TRD domain. This disappearance of 
residues is due to line-width broadening by interaction, suggesting a slow tumbling of 
TRD and MBP-MCAF1Δ8 complex (Fig 4.12). Moreover, the disappearance is 
oblivious in the presence of MBP alone. This is in accordance with the earlier study of 
TRD interaction with MCAF1 through Ile576 and Leu579 (Ichimura, Watanabe et al. 
2005). Interestingly, two previously uncharacterized but highly conserved charged 
residues, R583 and R585 of TRD were also found to be interacting with MBP: 
MCAF1Δ8-. 
b 
Marker        Fractions under peak E5-F10 
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Unlabeled full length MPG was titrated against 
15
N labeled TRD in the molar 
ratio of 1:0 to 1:3. A general attenuation in peak intensities per residue was observed 
but to a lesser extent compared to MCAF1Δ8 (Fig. 4.13). Significant intensity loss 
was observed for Glu545, Asp554, Trp590 and Leu591 of TRD. Thus we could infer 
that TRD interacts with both MCAF1 and MPG but in a different manner. More 
importantly, TRD remains intrinsically unstructured upon binding, indicating the 




N HSQC-TROSY of TRD titrated with protein. Titration 
was performed with the 
15
N TRD at molar ratios of 1:0 (black) and 1:3 (red). 
(a) with MBP:MCAFΔ8 and (b) with MPG. Chemical shift perturbation (Δδ) 
and intensity ratios of TRD (c) with MBP-MCAFΔ8 and (d) MBP alone, as a 
control (e) with MPG. The peak intensity ratio after and before titration is 
based on 
15
N-HSQC-TROSY. Gain/loss of interaction will lead to 
decrease/increase of peak intensity ratio, respectively. For any absence or 
similar interaction in free and bound TRD, the peak intensity ratio would be 1 








MCAFΔ8/ MPG are labeled in (a) and (b) and boxed between Thr574 and 
Ser594 in (c). The residues are numbered according to MBD1 isoform 1.  
 
4.4.4  GST pull down for TRD with MCAF1Δ8 and MPG 
 Following the interaction study results, GST pull down was performed, (Fig. 
4.13a). The GST pull-down results support the NMR interaction studies. Binding of 
MPG to TRD is weaker than that of MCAF1Δ8. The binding between TRD to 
MCAF1Δ8 and MPG is mostly due to the stretch of residues 571 to 592 of TRD 
where peak weakening occurs. The interaction between TRD and MCAF1Δ8 is not 
only due to the hydrophobic interaction involving Ile576 and Leu579 but also due to 
the charged residues Arg583 and Arg585, which are highly conserved, (Fig. 4.7). 
From the pull-down results, it could be seen that mutation of the charged residues to 
hydrophobic residues leads to loss of binding. This clearly shows that the binding is 
highly specific and in the case of MPG, mutation of even one residue causes loss of 





Figure 4.13. GST pull down of MCAF1Δ8 and MPG with TRD. (a) 
GST and GST- TRD proteins were immobilized on glutathione-
agarose beads and incubated with the 6xHis: MCAF1Δ8. Wild type 
(wt) and mutant (I576R, L579R, R583L and R585L) TRD proteins 
were tested. The input indicates 10% of the indicated proteins in the 
reaction mixture. (b) As in panel (a) but with 6xHis:MPG.  
 
4.4.5 Isothermal titration calorimetry (ITC)  
The interaction of TRD with MPG and MCAF1Δ8 was analyzed using ITC to 
determine affinity and the stoichiometry ratio. Earlier studies have indicated that the 
interaction is relatively weak and could be only transient in nature.. The Kd of TRD-
MPG interaction was 10 μM, with a stoichiometry close to 1 (Fig. 4.14a). The Kd of 
TRD-MCAF1Δ8 interaction was 10 μM with a stoichiometry of 0.9 (Fig. 4.14b). 






Figure 4.14. Interaction of TRD with MPG and MCAF1Δ8 using 
ITC. (a) TRD titrated against MPG. MPG did not saturate, but the heat 
exchange for each injection was recorded (b) TRD titrated against 






Table 4.1. Summary of the Values recorded in the ITC between TRD 






















1 MPG 1.044 
         
1.277   
0.1612 
7.8 -11.132   
0.0355 
-4.353 -6.779 
2 MCAF1Δ8  0.8386   
0.1004 
1.127 
          
























CHAPTER 5. DISCUSSION 
 
MBD1 is an essential cell signaling protein required to regulate neuronal cell 
differentiation and division (Liu, Teng et al. 2010). Its over expression is often linked 
to tumorigenesis by recruiting transcriptional repressor machinery, which 
unfortunately suppresses the tumor suppressor genes that are required to control 
invariably proliferating cells (Nakao, Matsui et al. 2001; Sakamoto, Watanabe et al. 
2007). Presently it is known that MBD1, as a transcriptional repressor, requires its 
transcription repressor domain (TRD) for interaction with different transcriptional 
repressor proteins in either a histone deacetylase dependent or independent manner. 
MBD1 could repress transcription in HDAC dependent manner in case of Acute 
Promyelocytic Leukemia through HDAC3 (Villa, Morey et al. 2006) and also in 
HDAC independent manner through MCAF1/AM family proteins to form 
heterochromatin (Ichimura, Watanabe et al. 2005). Other studies reveal that MPG is 
also part of such heterochromatin formation through its interaction with MBD1 via 
TRD (Watanabe, Ichimura et al. 2003). It has been shown earlier that cell signaling 
regulated by MBD1 involves the TRD domain. Earlier results have also clearly shown 
that MBD1ΔTRD (lacking TRD) is not efficient in transcriptional silencing albeit the 
other domains such as the DNA binding MBD domain and the CXXC domain are 
intact (Ng, Jeppesen et al. 2000). Thus TRD is a key part of MBD1 to act as a 
repressor and thus it is necessary to study its structure and mode of recognizing 
different binding partners.  
MCAF1 consists of two conserved domains, allowing the protein to interact 
with transactivator Sp1 and MBD1. MCAF1 can also act as an activator when it binds 
to transactivator Sp1 but at the same time, it acts as a transcriptional repressor when it 
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binds to MBD1 by further recruiting SETDB1 to form a strong heterochromatin 
complex (Fujita, Watanabe et al. 2003). The C-terminus of MCAF1 (MCAF1Δ8) is 
involved in interaction with TRD and a TRD deletion mutant of MBD1 is not able to 
bind MCAF.  
Here, NMR spectroscopy is used to elucidate both the structure of TRD and 
probe its interaction with MPG and MCAF1Δ8. We have found the TRD domain to 
be intrinsically unstructured. Besides the TRD domain, which is highly conserved 
among the seven isoforms (except isoform v6), we used constructs with 22 residues 
before the TRD domain. Notably, these 22 residues (Asp507 to Lys528) are only 
conserved among the four isoforms: v1, v5, v7 and v9. Next, an additional 13-residue 
sequence after the TRD domain is also highly conserved but not in isoforms v2 and 
v6, (Fig. 5.1a). Upon addition to MPG and MCAF1Δ8, an overall intensity loss across 
the TRD 99-residue sequence was observed after correcting the dilution effect. 
Interestingly, a previously uncharacterized stretch of residues (Thr574 to Ser594) 
disappeared in the presence of MPG. The same region also showed intensity loss in 
the presence of MCAF1Δ8 but to a lesser extent. Coincidentally, this 21-residue 
region lies within the 64-residue TRD domain and is rich in hydrophobic residues. 
Compared to the adjacent highly acidic region (Val537 to Ile573), both MPG and 
MCAF1Δ8 reduce the peak intensities more within this 21-residue hydrophobic 
region, bearing significantly fewer but conserved acidic (Glu575 and Asp586) and 
basic (Arg583 and Arg585) Residues. Moreover, there was no great loss in intensity 
in another hydrophobic region (Asp507 to Ala536). Ichimura and co-workers have 
previously shown that mutation of two residues (Ile576 and Leu579) of TRD to basic 
Arg residues clearly abolished MBD1 binding to MCAF (Ichimura, Watanabe et al. 
2005). We further investigated the need for more favorable hydrophobicity. 
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Surprisingly mutating two basic residues to hydrophobic residues, R583L and R585L, 
did not enhance TRD binding to both MPG and MCAF1Δ8 but there was a significant 
loss in binding. To check whether the double mutant of charged residues has the same 
structure as the wild type, a 
15
N HSQC spectrum of the R583L/R585L mutant protein 
was collected and it showed similar well-resolved peak pattern as the native TRD, 
suggesting no protein aggregation, (Fig. 5.1b). The key differences are only the 
appearance of two new peaks in the place of the mutated R583L and R585L residues, 
and peak shifts of residues Ile576 and Leu579, which were only minimally perturbed 
due to local chemical changes near the point mutations (Fig. 5.1a). Additionally, both 
Arg583 and Arg585 are not conserved in isoform v6 only, suggesting a unique 
recognition motif within the primary binding site (TRD domain) for the remaining six 
isoforms. Hence, the newly identified charge-charge interactions of TRD with MPG 
and MCAF1Δ8, besides the previously reported Ile576 and Leu579, are crucial. 
Furthermore, the formation of the TRD-MCAFΔ8 or TRD-MPG complexes was 
further confirmed by GST pull-down assays.  
The need for this charge-charge interaction within the primary TRD domain 
can be attributed to compensate the lack of conformational fit. Perhaps, this lack of 
globular fold may enable the unstructured TRD domain to act as a recognition domain 
to sample a wider gallery of binding proteins and fueled by electrostatic forces. 
Notably, the TRD-protein interaction is weak and does not induce visible 
conformational changes in TRD. The weak interaction is seen by the negligible 
chemical shifts in 
15
N HSQC and line-width broadening, suggesting a slow tumbling 
complex. The unique mode of partner proteins recognition through weak but specific 
interaction may enable MBD1 to shuffle between at least two different functional 
forms for regulating a cobweb of cell functions, primarily through its TRD domain.  
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While MBD1 is an important cell signaling protein to maintain normal cell 
function, it plays a significant role at the same time during tumor progression in a 
promoter methylation dependant manner. It is obviously essential to control its 
activity and this may be achieved by targeting its interaction with other repressor 




Figure 5.1. Conservation of TRD between MBD1 isoforms and the 
HSQC Spectra for the Double mutant. (a) Multiple sequence 
alignment of TRD of MBD1 isoforms (b) 
15
N HSQC spectra for the 




We could design peptide inhibitors corresponding to the core residue stretch 
(Thr574 to Ser594) that interacts with MCAF1, MPG and HDAC3. Targeted silencing 
of these 21 residues to prevent the interaction between TRD and its binding partners is 

























CHAPTER 6. MITOCHONDRIAL DYSFUNCTION PROTEIN A 
(MIDA) 
 
In this part of the thesis, I will discuss about the structure of the MidA protein, 
determined by X-ray crystallography. MidA has a methyltransferase domain, which 
binds to co-factors and a substrate binding domain. From our structure we could come 
up with the important residues of MidA that are involved in binding co-factors 
required for methylating substrate. MidA is an important member of the 
mitochondrion, since it helps in proper Mitochondrial Complex I formation and is 
also presumed to methylate one of the sub-units in Complex I. 
 
6.1 THE MITOCHONDRION 
    The mitochondrion is an important sub-cellular organelle and plays a major 
role in energy metabolism. Its outer membrane contains high concentrations of porins, 
which facilitate the permeability of solutes, whereas the inner membrane is 
impermeable to metabolites and ions (Jonckheere, Smeitink et al. 2012). A family of 
about 50 mitochondrial carriers has been discovered in the human genome which 
enable exchange between the inter-membrane space and matrix (Kunji 2004). The 
inner membrane contains protein complexes and redox cofactors that are involved in 
electron transfer and ATP synthesis (Boyer 1997). The mitochondrial matrix, 
encapsulated by the inner membrane, contains a mixture of enzymes that are involved 
in all aspects of metabolism, in addition to the mitochondrial genome, with 39 genes 
in mammals, known to be important for mitochondrial function.  
The mitochondrion is known to form highly dynamic and interconnected 
tubular networks throughout the cell, fusing and dividing, and undergoing regulated 
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turnover, enabling it to readily adapt to changes in the cellular environment (Egner, 
Jakobs et al. 2002). Disruption of mitochondrial dynamics results in cellular 
dysfunction and several major neurodegenerative pathologies, including Parkinson's, 
Alzheimer's and Huntington's diseases. Remarkably, in several disease models, the 
manipulation of mitochondrial fusion and fission can partially rescue disease 
phenotypes (Chen and Chan 2009). 
In contrast to the traditional ‘baffle model’ of mitochondrial structure, Fig 6.1 
shows how invagination of cristae from the mitochondrial inner membrane and 
throughout the matrix produces compartments that are likely to impede the lateral 
diffusion of metabolites (Mannella 2006). These cristae junctions have great 
importance in the regulation of metabolic processes within the mitochondrion, and 
also in other processes that are key to cellular biochemistry, such as apoptosis. The 
model reveals the point of contact between the inner and outer mitochondrial 
membranes, postulated to be the sites of large macromolecular assemblies involved in 
metabolite transport into and out of the mitochondrion (Frey and Mannella 2000). 
 
Figure 6.1 The Mitochondrion. Computer models generated from 
segmented 3D tomograms of a mitochondrion in chick cerebellum. (a) 
The entire model showing all cristae in yellow, the inner boundary 
membrane in light blue, and the outer membrane in dark blue. (b) 
Outer membrane, inner boundary membrane and four representative 
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cristae in different colors. Figure adapted from (Frey and Mannella 
2000). 
 
6.2 MITOCHONDRIAL FUNCTIONS 
6.2.1 Energy transduction 
Energy transduction in the mitochondrion is carried out by five protein 
complexes located in the inner membrane. A flavin mononucleotide, which is non-
covalently bound to NADH:ubiquinone oxidoreductase (complex I), is reduced by the 
low potential electrons of NADH. Subsequently the electrons are passed down to a 
series of redox centres, approximately arranged in the order of increasing potential, 
until they are used up to reduce molecular oxygen. Thus released energy is used to 
pump protons across the impermeable mitochondrial inner membrane into the inter-
membrane space. This proton motive force is used by ATP synthase to synthesize 
ATP from ADP (Jonckheere, Smeitink et al. 2012). In addition to oxidative 
phosphorylation, the mitochondrion also plays an important role in upstream of the 
electron transfer chain reactions, including the citric acid cycle. Recent studies clearly 
show that, impairment in the components of the citric acid cycle could also result in 
tumor formation (Raimundo, Baysal et al. 2011).  
 
6.2.2  Apoptosis 
It is well known that the mitochondrion plays a central role in apoptosis, 
which is important in many physiological and pathological processes. The Bcl-2 
family of proteins controls the cell death by regulating the permeability of the 
mitochondrial outer membrane and the release of pro-apoptotic factors. The formation 
of mitochondrial apoptosis induced channels is important for the regulation of 
apoptosis by the Bcl-2 family of proteins. Pro-apoptotic members, such as Bax and 
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Bak, promote the formation of channels, whereas anti-apoptotic members inhibit the 
formation of channels (Rodriguez, Rojas-Rivera et al. 2011). 
 
6.3 MITOCHONDRIAL COMPLEXES 
The mitochondrial respiratory chain (RC) assembly consists of, as shown in 
Fig. 6.2, four membrane-bound (Complex I, II, III and IV) multimeric RC complexes 
(RCCs) and function as a catalyst for the oxidation of reducing equivalents, 
importantly of nicotinamide adenine dinucleotide (NADH), using oxygen (O2) as 
terminal electron acceptor in the inner mitochondrial membrane (IMM) (Lenaz and 
Genova 2010). The electron transfer mediated by the RC is connected to ATP 
synthase (complex V), the final complex that generates ATP. The coupling between 
ATP synthesis and RC is called oxidative phosphorylation (OxPhos) (Lemarie and 
Grimm 2011). 
Reactive oxygen species (ROS) are generated if electron leakage occurs in RC 
(Lemarie and Grimm 2011). In many cancer cells, deficiencies in RC are frequently 
observed mainly due to numerous mutations in the mitochondrial genome (mtDNA), 
which directly affect the subunits in RCC I, III and IV (Polyak, Li et al. 1998), and in 
the nuclear-coded components of complex II (Hensen and Bayley 2011), whose 
assembly factors are also found to be mutated (Ghezzi, Goffrini et al. 2009). These 




Figure 6.2. Respiratory Chain Complex. Representation of the 
mitochondrial respiratory chain complexes and the oxidative 
phosphorylation system. Figure adapted from (Lemarie and Grimm 
2011). 
 
6.3.1 Mitochondrial complex I 
Complex I (CI), comprising of NADH:ubiquinone oxidoreductase or NADH 
dehydrogenase, is the largest of the mitochondrial respiratory complexes, with 45 
subunits. Seven subunits are encoded by the mtDNA while others are encoded by the 
nuclear DNA. CI is involved in the catalysis of the transfer of electrons from NADH, 
which is produced during the tricarboxylic acid cycle (TCA) to coenzyme Q. A recent 
effort to study the three-dimensional structure using electron microscopy and 
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crystallographic studies reveal that the structure of the complex resembles an ‘L’ with 
the presence of a peripheral hydrophilic arm (matrix arm) and a highly hydrophobic 
membrane arm, (Fig 6.3) (Tocilescu, Fendel et al. 2007; Clason, Ruiz et al. 2010). 
 
Figure 6.3. Overall structure of the peripheral arm of T. 
thermophilus complex I. It shows the wire of iron-sulfur clusters 
connecting the NADH-binding site near FMN with a broad cavity 
formed by the PSST and the 49-kDa subunit that should comprise the 
active site for ubiquinone reduction and the binding region for the 
large number of inhibitors that have been found for complex I. Figure 
adapted from (Tocilescu, Fendel et al. 2007).  
 
    The assembly of this enzyme is quite elaborate, and even though many steps 
have been identified in mutants of Neurospora crassa and by studies of patients with 
CI defects, the complete sequence of events need to be determined. Various models, 
which vary in details but with several common features, have been proposed for the 
assembly of the holoenzyme. The complex is assembled in several modules that go on 
to form the peripheral and membrane arms (Mckenzie and Ryan 2010; Perales-
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Clemente, Fernández-Vizarra et al. 2010). Patients will have severe manifestations 
during birth and early childhood whenever there are mutations of nuclear origin 
leading to CI defects, which very often lead to premature death (Kirby, Crawford et 
al. 1999). Various mutations in CI nuclear and mtDNA-encoded subunits have been 
reported and part of the CI deficiency cases are due to mutations in the structural 
subunits (Distelmaier, Koopman et al. 2009). CI defects are also due to mutations in 
auxiliary proteins, which do not form part of the final holoenzyme but assist in the 
assembly process (Küffner, Rohr et al. 1998). In addition to the Complex I, other 
complexes such as Complex II, III, IV and V plays important roles in the oxidative 
phosphorylation which controls various steps of the electron transport chain (Lemarie 
and Grimm 2011). 
 
6.2  METHYL TRANSFERASES 
 A protein methyl transferase enzyme employs a common bimolecular 
nucleophilic substitution (SN2) methyl transfer mechanism (Zhang and Bruice 2008; 
Smith and Denu 2009). The lone pair electrons of a nitrogen atom (either from lysine 
or arginine) ‘attacks’ the electrophilic methylsulphonium cation of SAM (S-
Adenosyl-L-Methionine) at an angle of 180° to the leaving group, to form a penta-
coordinate carbon transition state, which then collapses. The methyl group gets 
relocated to the nitrogen atom of the lysine or arginine side chain and forms S-
adenosyl-l-homocysteine (SAH; also known as AdoHcy) as a product, (Fig 6.4).  
 The two highly studied methyl transferases, owing to their importance in cell 
signaling are protein lysine methyl transferase (PKMT) and protein arginine methyl 
transferase (PRMT). The common structural feature of these two types, which 
differentiates them from other proteins that use SAM, is confined to the overall 
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architecture of their extended catalytic active sites. They generally consist of a SAM-
binding pocket that can be accessed from one face of the protein and a narrow and 
hydrophobic acceptor (lysine or arginine) channel, which extends to the opposite face 
of the protein surface, in a way the two substrates enter the active site from opposite 
sides of the enzyme surface (Cheng, Collins et al. 2005). 
 
Figure 6.4. Protein methyl transferase. PMT- catalyzed methylation 
of proteins by an SN2 reaction with SAM as the methyl donor. (a) The 
methyl group of the SAM is ‘attacked’ by the lone pair electrons of a 
lysine side-chain nitrogen atom and it results in transfer of the methyl 
group to the attacking nitrogen atom and the production of SAH from 
the reaction cofactor. (b) A more generalized chemical scheme of a 
bimolecular nucleophilic substitution (SN2) group transfer. Figure 
adapted from (Copeland, Solomon et al. 2009). 
  
6.3  MITOCHONDRIAL DYSFUNCTION PROTEIN A (MIDA) 
6.3.1  MidA belongs to an uncharacterized protein family 
 MidA was first identified in Dictyostelium from a group of 30 uncharacterized 
proteins with highly conserved sequences, (Fig. 6.5a). MidA is important for the 
normal cell functioning of Dictyostelium, since the knockdown of MidA resulted in 
pleiotropic effects. A large part of mutant cells had a diameter of 8-12 μm, but wild-
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type cells displayed a wider distribution and also a significant proportion of cells were 
more than 12 μm in diameter (Fig. 6.5b). In supportive to the data, the amount of total 
protein per cell was also found to be to 70% less than that of wild type (Torija, 
Vicente et al. 2006). Macropinocytosis responsible for most of fluid-phase uptake 
(Hacker, Albrecht et al. 1997), and phagocytosis accounts for the uptake of particles 
in bacteria (Maniak 2001). In the mutant cells, both the processes were down 
regulated as shown in (Fig 6.5c). The level of uptake of fluorescent particles and 
fluorescent soluble material was found to be less in the mutant, after 30 minutes of 
incubation (Torija, Vicente et al. 2006). Flow-cytometry also confirmed that the 
number of cells that were able to ingest multiple fluorescent microspheres was 
reduced in midA
–
 cells, (Fig. 6.5d). Even though MidA was initially thought to be an 
uncharacterized and non-functional protein, the above results clearly show the 
conservation from bacteria to human and knock out of MidA results in defects of 
physiological functions in Dictyostelium. Thus it can be inferred that MidA plays an 








Figure 6.5. Knock out of MidA in Dictysotelium. (a) Multiple 
Sequence Alignment of MidA from bacteria to humans (b) Cell 
diameter of mutants enlarged compared to wild type (c) Phagocytosis 
and Macropinocytosis is reduced in mutant cells (d) The uptake of 
fluorescent labeled materials is reduced in mutant cells. Figure adapted 
from (Torija, Vicente et al. 2006). 
 
6.3.2 Loss of MidA results in mitochondrial dysfunction 
 The localization of MidA in cells was determined by the expression of green 
fluorescent protein (GFP) fused to the C-terminal end of the Dictyostelium full length 
MidA protein. The expression of this construct was supported by the actin15 
promoter. Furthermore, transfection into midA
– 
cells has shown recovery in growth 
rate in bacteria (Fig. 6.6). The recovery strains were monitored with confocal 
microscopy for GFP fluorescence and the GFP distribution showed a punctuate 
pattern, which co-localized with the mitochondrial specific marker MitoTracker Red 






Figure 6.6. Localization of MidA in mitochondria. (a) The construct 
used for expression of GFP fused to MidA. (b) Effect of deletion of MidA 
in mutant and rescue with MidA expression (c) The localization of GFP 
fused MidA and mitochondrial specific marker (MTR), where Series of 
2μm confocal images from the same cell show GFP location in green and 
the mitochondrial marker in red. Figure adapted from (Torija, Vicente et 
al. 2006).  
 
The reason for such defects in mutants in mitochondrial function was analyzed 
using MitoTracker Red (CMXRos), which get incorporated to active mitochondria 
and in a way that depends on the mitochondrial membrane potential (MMP) 
(Pendergrass, Wolf et al. 2004). The cells that were stained with these markers can be 
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observed by fluorescent microscopy and quantitatively analyzed fluorimetry. There 
was no change in the level of intensity in staining of these markers, suggesting that 
the amount of mitochondria per cell and the MMP was not affected in the mutant. The 
cellular oxygen consumption was also found to be unaffected in midA
–
 cells (Fig. 6.7). 
Interestingly, the amount of ATP per cell was about 70 % less than that of the wild 
type which could be the probable reason for the mitochondrial defect. 
 
Figure 6.7. Effects of MidA knock out in mitochondria. (a) 
Mitrotracker red level marks active mitochondria (b) the level of 
mitochondrial membrane potential in mutant and WT (c) the level of 
ATP production in mutant and WT (d) the level of oxygen 
consumption in mutant and WT. Figure adapted from (Torija, Vicente 
et al. 2006).  
 
6.3.3 MidA is important for complex I formation in mitochondria 
The importance of MidA in complex I formation was analyzed by measuring 
the level of activity in the OXPHOS complexes (I, II, III and IV) in midA
– 
null 
Dictyostelium. About 50% decrease in the activity of CI in Dictyostelium was 
observed (Fig. 6.8). It was quite interesting to see that the activity of other complexes 
remain unaffected and or significantly higher in the mutant (Carilla-Latorre, Gallardo 
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et al. 2010). This could be due to the compensatory response to the loss of CI activity. 
In support, there was an increase in the level of mtDNA and most mtRNA transcripts 
in the mutant (Fig 6.8). Also an insignificant increase in the level of citrate synthase 
was observed in the mutant cells.  
 
Figure 6.8. The activity of complex I is reduced in cells lacking 
MidA. (a) The level of activity of the OXPHOS complexes in the WT 
and Knockout cells. (b) The level of mtRNA transcripts level in mutant 
cells (c) The expression level of citrate synthase in mutant and WT, 
and also mtDNA in mutant. Figure adapted from (Carilla-Latorre, 
Gallardo et al. 2010). 
 
 The level of complex I assembly was analyzed using blue native (BN) Poly 
Acrylamide Gel Electrophoresis (PAGE) in a stable transfection cell line of 
HEK293T in which the human MidA protein was down regulated by the shRNAmir 
(micro RNA adapted shRNA) technology. HEK293T cells transfected with the 
scramble vector was used as a control. Quantification by densitometry of three 
independent experiments is shown, (Fig. 6.9), and it was seen only the clones S1 and 
S19 produced a significant reduction in the level of MidA and because of that there 






determined by spectrophotometric analysis, is also reduced to 75%. These results 
confirm the involvement of MidA in complex I assembly or stability (Carilla-Latorre, 
Gallardo et al. 2010). 
 
Figure 6.9. Down regulation of MidA results in reduction of fully 
assembled complex I. (a) Blue-native gel shows the level of complex 
assembly in the cell, where MidA is knocked down. S1 and S9 mark 
different shRNA clones. (b) Spectrophotometric analysis of Complex I 
assembly in the knock down cells (Figure adapted from : (Carilla-
Latorre, Gallardo et al. 2010). 
 
6.3.4  MidA interacts with ndufs2 subunit of mitochondrial complex I 
 To identify the proteins that interact with MidA, a yeast two hybrid screen was 
carried out using the whole Dictyostelium MidA protein, except for the first 21 amino 





Dictyostelium NADH-ubiquinone oxidoreductase chain 49, a homologue of the 
human complex I subunit NDUFS2. Fig. 6.10 shows the common region that is 
present in different clones which helped in restraining the minimal interaction region 
to 40 amino acids. To validate this result, pull down assays were performed and the 
N-terminal fragment of Dictyostelium NDUFS2, which contains the minimal region 
of interaction, was fused to GST, incubated with cell extracts from Dictyostelium 
expressing MidA, which was fused to GFP. MidA-GFP was pulled down by GST-
NDUFS2 and even the human MidA was pulled down. This again confirms the 
interaction between MidA and NDUFS2 as well as the functional conservation 
between Dictyostelium and human MidA proteins (Carilla-Latorre, Gallardo et al. 
2010). 
 
Figure 6.10. MidA interacts with NDUFS2. (a) The clones that were 
found to be positive in a yeast-two hybrid screen. (b) GST Pull down 
of Dictyostelium and human MidA by NDUFS2. Figure adapted from 








6.3.5  MidA has a methyl transferase domain 
 The MidA sequence was compared to all known structures from the Protein 
Data Bank. Even though the MidA protein is of unknown function, the structural 
similarity showed that it has a methyl transferase domain similar to the human 
dimethyl adenosine transferase, which belongs to the family of S-adenosyl-L-
methionine (SAM) dependent transferases. Based on homology modeling, the 
important residues involved in SAM binding were speculated to be Gly170, Glu200 
and Asn257. Furthermore, G170V and G172V mutants were prepared and the effect 
of these mutations in Dictyostelium was studied. Both residues have previously been 
suggested to be important for SAM binding, and are well conserved among 
methyltransferases (Niewmierzycka and Clarke 1999).  
 
Figure 6.11. Importance of SAM binding residues of MidA. (a) 
Schematic diagram of the mutation and the lone (b) Localization of 
mutant in the mitochondrion. (c) WT MidA protein is able to 
complement in the MidA
-
 null cells but the G170V mutant protein 
failed (Carilla-Latorre, Gallardo et al. 2010).  
 
The WT and mutated forms of MidA were fused to GFP to visualize their expression 
and localization and transformed into the Dictyostelium MidA
-






6.11). As known earlier, MidA
-
 cells showed defects in growth in both axenic medium 
and in association with bacteria, as a consequence of mitochondrial dysfunction 
(Torija, Vicente et al. 2006). The WT protein was able to complement the phenotype 
completely, but the G170V mutant protein was unable to complement the phenotype. 
The lack of reversing the phenotype confirms that the single mutation in Gly170 from 
the methyltransferase domain is enough to make the protein ineffective. These results 





1. To determine the crystal structure of MidA and its complex with SAM and 
SAH using X-ray crystallography 
2. To validate the structure by performing site-directed mutation of important 
residues and verified by biophysical studies such as ITC 
3. To model MidA complex with NDUFS2 and validate it by experiments 
4. To determine the importance of MidA as a methyl transferase in the 










CHAPTER 7. MATERIALS AND METHODS 
 
7.1  SUBCLONING 
 The gene encoding residues 76 to 484 amino acids was PCR amplified using 
Pfu DNA polymerase (Fermentas) with the forward primer ATTGGATCCAAA 
CAAGTTTTCAAAAATAG containing a BamHI site (underlined) and the reverse 
primer ATTCTCGAGTTAAATCATTAAATCTT CATCATCATAAG with an XhoI 
site and sub-cloned into the pGEX6P-1 vector with N-terminus GST tag.  
 
7.2  PROTEIN EXPRESSION AND PURIFICATION 
 The MidA protein was over-expressed using the pGEX 6P-1 vector as an N-
terminal GST-fusion protein. Seed cultures of transformed E. coli BL21 (DE3) 
competent cells were added to large scale LB medium containing 100 μg/ml 
ampicillin. The cell density was monitored until A600nm was 0.6 to 0.7, before adding 
0.15 mM IPTG for protein over-expression for another 18h at 16 °C. Cells were 
harvested and cell pellet was stored at -80 °C. The cell pellet was resuspended in 
binding buffer A: 50 mM Tris-HCl buffer, 150 mM NaCl, 2mM DTT, 5% Glycerol, 
0.1% Triton X-100 and its final pH adjusted to 8.5. The cell suspension was lysed by 
sonication on ice and the supernatant was loaded onto a GST column (GE Healthcare) 
and subsequently allowed to bind for 4 h at 4 °C. Weakly bound proteins were 
removed by extensive washing using buffer A for 3 to 4 times. The GST tag was 
cleaved off with Prescission Protease overnight using 1unit/mg of GST:MidA at 4 °C. 
Thus purified protein was passed through a Superdex 200 column (GE Healthcare) 
equilibrated with 20 mM HEPES, 200 mM NaCl and 3 mM DTT, pH adjusted to 8.0. 
MidA eluted as a single homogenous peak, at its theoretical Mol. Wt. of 45 kDa. The 
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purified protein was concentrated to 5 mg/ml using ultra filtration membrane (Merck 
Millipore) with 10 kDa Mol. Wt. cut off. The same protocol was followed for the 
seleno-methionine derivative protein. 
 
7.3 CRYSTALLIZATION, DATA COLLECTION AND STRUCTURE 
DETERMINATION 
  The purified MidA protein was mixed with cofactors S-adenosyl-L-
methionine (SAM) and S-adenosyl-homocysteine (SAH) in a ratio of MidA:SAM (or 
SAH) 1:20 and setup for crystallization using commercial screens using the hanging 
drop method in VDX plates (Hampton Research) where 1 μl of MidA, MidA:SAM or 
MidA:SAH was mixed with 1 μl of the corresponding reservoir solution and allowed 
to equilibrate against 1 ml of the reservoir solution at room temperature. Crystal 
appeared in a few hours and grew to maximum size of 0.1-0.2mm in one day. Initial 
crystals were obtained for MidA alone and MidA:SAH complex in Wizard Screen III 
(Emerald Biosystems) contain 10% PEG8K, 0.1 M HEPES pH 7.5 and 8% ethylene 
glycol and for MidA:SAM complex in PEGRx 2 (Hampton Research) containing 10% 
PEG10K, 0.1 M HEPES pH 7.5 and 0.2 M sodium potassium tartrate. The seleno-
methionine derivative protein was also crystallized using the same condition. 
Crystals were cryoprotected in the reservoir solution supplemented with 20% 
glycerol and flash cooled at 100 K. Since MidA has 11 methionines, the structure was 
solved by the multi wavelength anomalous dispersion (MAD) method (Terwilliger 
and Berendzen 1997). X-ray diffraction data were collected at beamline 13B, National 
Synchrotron Radiation Research Centre (NSRRC), Taiwan using a Quantum-315r 
CCD area detector (ADSC) and processed with HKL2000 (Otwinowski and Minor 
1997). All Se sites in the asymmetric unit were located for the MidA:SAH complex 
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using the program Phenix-Autosol (Terwilliger, Adams et al. 2009). Phases were 
further improved by density modification using RESOLVE (Terwilliger 2003). Over 
50% of the backbone atoms of the model were built by RESOLVE. The remaining 
residues were manually built using COOT (Emsley and Cowtan 2004), followed by 
refinement using phenix-Refine (Adams, Afonine et al. 2010). Refinement was 
continued until the R-value converged to 0.20 (Rfree = 0.255) for reflections I>σ (I) to 
2.8 Å. For determination of MidA and MidA-SAM structures, molecular replacement 
was performed using the program Phaser-MR (Simple Interface) from phenix 
(McCoy, Grosse-Kunstleve et al. 2007) with the MidA:SAH structure used as the 
template model and refined using Phenix-Refine until the R value converged to 0.214 
(Rfree = 0.274) for MidA with reflections I>σ (I) to 2.8 Å resolution and for 
MidA:SAM complex until R was 0.206 (Rfree 0.251) for reflections I>σ (I) to 3.0 Å. 
About 4.97% of reflections were used for Rfree calculation. 
 
7.4 PROTEIN-PROTEIN DOCKING FOR MIDA WITH NDUFS2 
 MidA is known to interact with the NDUFS2 subunit of mitochondrial 
Complex I (Carilla-Latorre, Gallardo et al. 2010), primarily at the N-terminus of 
NDUFS2. As no experimental structure is available for NDUFS2, its 3D model was 
built using the CPH model 3.0 server (Nielsen, Lundegaard et al. 2010). This model 
was then docked against the MidA structure using the Cluspro 2.0 protein-protein 
docking server (Comeau, Kozakov et al. 2007; Kozakov, Hall et al. 2010). The output 
of Cluspro was analyzed using the CONTACT program of CCP4. The residues within 





CHAPTER 8. RESULTS 
 
8.1  PROTEIN EXPRESSION AND PURIFICATION 
 Residues 76-484 (of 484 aa) of the MidA protein, also known as NADH 
dehydrogenase (ubiquinone) complex I assembly factor 7 was cloned into the pGEX 
6P-1 vector and overexpressed in BL21 (DE3) cells. The overexpressed protein was 
purified by two step purification, first with GST, following which the N-terminal GST 
tag was cleaved overnight at 4 °C using Prescission protease, and then by size 
exclusion chromatography. The protein was eluted as a monomer, corresponding to 
45 kDa (Fig. 8.1). The fractions were verified by SDS-PAGE, Fig. 8.2. 
 
Figure 8.1. Size exclusion chromatography of MidA.  
 
 
Figure 8.2. SDS-PAGE of the fractions of Fig. 8.1.  
kDa  







       Fractions under peak E1-E15        Marker 
Volume (ml) in S200 Column 
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The MidA protein was concentrated to 5 mg/ml and its homogeneity was analyzed 
using dynamic light scattering (DLS). The results confirm that MidA is homogenous 
with a polydispersity index of 9% (limit is 20%), radius 4.25 nm and SOS error 5.51 
(limit is 50), Fig. 8.3. 
 
 
Figure 8.3. DLS of MidA at 5mg/ml. 
 
8.2  CRYSTALLIZATION AND STRUCTURE DETERMINATION 
8.2.1 Crystallization 
 MidA was concentrated to 5 mg/ml and then screened for crystallization using 
various commercial screens. Several conditions gave crystals but with poor 
diffraction. The seleno-methionine derivative protein gave a crystal in a condition 
containing 8% ethylene glycol, 0.1 M HEPES pH 7.5 and 10% PEG 8000 at room 
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temperature in about 16 to 24 hours (Fig. 8.4). Cryo-protected (with 25% glycerol) 
crystals diffracted to 3.0 Å resolution. Also, MidA was mixed with 20 times excess S-
adenosyl-homocysteine (SAH), which is a cofactor, and setup for crystallization. 
MidA:SAH crystal, produced at the same condition, diffracted to 2.8 Å. 
 
 
Figure 8.4. Crystal of MidA. (a) Crystals of apo MidA and (b) 
MidA:SAH. 
 
8.2.2  Structure determination 
 MidA has 11 methionines and the structures of Se-Met apo MidA and 
MidA:SAH complex were solved by the single wavelength anomalous dispersion 
(SAD) method (Hendrickson et al., 1990). The MidA:S-Adenosyl-L-Methionine 
(SAM) complex structure was solved by molecular replacement using the MidA:SAH 
structure as the starting model (Table 8.1 and Fig. 8.5). Electron density for the N-
terminal residues 124 to 133 was not well defined and the residues were not modeled. 
The asymmetric unit consists of three MidA molecules, without any local non-
crystallographic symmetry (NCS). Refinement details for apo MidA and the 






      
    
Figure 8.5. Crystal structure of MidA. (a) The three MidA:SAH 
molecules in the asymmetric unit (b) MidA:SAH monomer and (c) apo 
MidA molecule. 
 
MidA adopts a Class I methyltransferase fold consisting of a parallel seven-
stranded β sheet and a pair of α-helices (Fig. 8.6). A search for structurally similar 









2008), (Table 8.1). MidA shows the highest structural similarity to certain proteins, 
whose functions are still unknown. However, they are likely to be methyl transferases. 
Furthermore, MidA matches with the carboxy methyl transferase-1, which methylates 
the terminal carboxyl group of leucine of protein phosphatase 2A (PP2A) in humans. 
Based on sequence and structural homology, MidA is proposed to be a 
macromolecular methyltransferase, which could methylate either proteins or DNA or 
RNA molecules in cell signaling.  
The central region, residues Thr135 to Leu263, binds the co-factors SAM or 
SAH. In addition, residues Ile265 to Gly344, which also interact with the N-terminal 
helices, could be the region that binds substrate. According to DALI, MidA shares 
structural similarities with other Rossmann Fold Methyltransferase (RFM) proteins 
with predicted or determined methyltransferase activity. There are evidences that 
MidA is as an important assembly factor in mitochondrial complexI NADH 
dehyrogenase (ubiquinone) complex I assembly factor 7 (NDUF7), in addition to its 
possible methyltransferase activity on selected components of complex I. 
 
8.2.3  MIDA interaction with SAM and SAH 
 The ligands in MidA:SAM and MidA:SAH complexes display a similar mode 
of binding (Fig. 8.7). The highly conserved consensus motif hh(D/E)hGxGxG, where 
h represents a hydrophobic residue and x can be any residue, mostly involved in SAM 
binding (Niewmierzycka and Clarke 1999) is present in the loop between residues 
Ile166 to Gly174. This loop connecting a β-strand to its successive α-helix forms the 
bottom of the cofactor-binding site, while residues Thr135, Gly170, Pro171, Gly172, 
Glu200, Asn205, Gln257 and Phe259 delineate the cofactor-binding site. Residues 
Gly170 and Glu200 are highly conserved in class I SAM dependent MTases and are 
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involved in cofactor binding. The hydroxyl group of Thr135 interacts with the 
carboxylic group of SAH or SAM and Glu200 coordinates both hydroxyls of the 
ribose moiety. In particular, the side chain of Gln257 (like its equivalent in other 
related enzymes) coordinates the exocyclic amino group of the SAM adenine moiety, 
while Gly170, Gly172 and Asn205 are engaged in hydrogen bonds with the cofactor 
via their backbone. The adenine moiety is stacked towards Phe259, where the 
hydrophobic benzene ring forms stacking interaction with the hydrophobic indole 
group of the adenine ring and Pro171 helps in formation of a pocket to hold the co-
factors. In total, Thr135, Gly170, Gly172, Glu200, Asn205 and Gln257 will form six 
hydrogen bonds with SAM/SAH. The cofactor binding site in apo-MidA is highly 
similar to that of the MidA–SAM/SAH complex. 
 
Figure 8.6. Topology Diagram of MidA. α-helices are shown as red 
cylinders while β-strands are shown as pink arrows. The figure was 
drawn with the PDBsum online server. 
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1 1zkd 42.0 2.0 349 35 Rhodopseudomonas 
palustris 
Q6N1P6 




3 3mnt 13.8 3.6 204 11 Homo sapiens Leucine carboxyl 
methyltransferase-1  




























8 3ha5 13.2 3.5 201 9 Mycobacterium  
Tuberculosis 
Methoxy mycolic 
acid synthase 4 




Table 8.2. Data collection and refinement statistics of MidA structure. 
Data collection  Native  SAM  SAH  
    
Unit cell (Å):  a=72.82 b=105.39, 
c= 201.57  
a=72.85 b=106.04, c= 200.77  a=73.04 b=105.64, c= 201.12  



















Resolution range (Å):  50.0-2.8 (2.85-2.80)  50.0-2.9 (2.95-2.90)  50.0-2.80 (2.90-2.80)  
Wavelength(Å):  0.97879  0.97864  0.96357  
Observed reflections:  421912  256356  541083  
Unique reflections:  38951  35124  38959  
Completeness (%):  99.7(98.9)  100 (100)  100(99.9)  
Overall (I/σI):  12.5  11.3  11.0  
Redundancy:  10.8(9.5)  7.3(7.0)  13.9(11.8)  
R Sym:  0.17  0.18  0.18  
Refinement and quality     
Resolution range:  32.0-2.8  32.0-2.90  32.0-2.80  
R work:  0.248  0.244  0.190  
R free:  0.275  0.278  0.242  
RMSD bond length (Å)  0.009  0.009  0.010  
RMSD bond angles (Degree)  1.097  1.144  1.365  
Average B factors  
Main Chain:  







Ramachandran Plot  
Most Favoured regions (%)  
Additionally allowed regions 
(%)  
Generously allowed regions (%)  















Rsym=∑|Ii - <I>I|/∑|Ii|, where Ii is the intensity of the i-th measurement, and <I> is 
the mean intensity for that reflection.  
 
b
Rwork=∑||Fobs| - |Fcalc||/∑|Fobs|, where Fcalc and Fobs are the calculated and 
observed structure factor amplitudes, respectively. 
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Figure 8.7. MidA Interaction with SAM/SAH. (a) Electrostatic 
surface of MidA, where S-Ado Hcy is bound at the pocket (b) MidA 
residues involved in interaction with SAM (c) MidA residues involved 
in interaction with SAH (d) Superimposition of COG1565 super-
family member (PDB 4q67, colored in cyan blue) and MidA residues 
(colored in green) involved in interaction with SAH. The figure was 





8.3.  DOCKING MODEL OF MIDA-NDUFS2 INTERACTION 
 NDUFS2 is an important subunit of mitochondrial Complex I and is part of 
the catalytic core (Loeffen, Elpeleg et al. 2001). It interacts with MidA through its N-
terminal 40 residues, Val11 to Gly51 (Carilla-Latorre, Gallardo et al. 2010). Earlier 
reports show that human NDUFS2 is methylated at Arg323 (Loeffen, Elpeleg et al. 
2001) and hence NDUFS2 might be a substrate for MidA (Carilla-Latorre, Gallardo et 
al. 2010). It is important to know the structure of the MidA: NDUFS2 complex which 
will provide more insight about the mode of interaction and the signal cascade 
between the two proteins. The knowledge of this interaction will enable us understand 
about mitochondrial disorders.  
a       b 
 
Figure 8.8. MidA-NDUFS2 interaction model. (a) A docking model for MidA: 
NDUFS2 interaction (MidA is shown in purple and NDUFS2 shown in orange color 
respectively) (b) A close-up view showing electrostatic and hydrogen bonding. The 
figure was drawn with the Pymol program.  
 
The MidA:NDUFS2 complex structure was prepared using the Bioinfromatic server 
Cluspro 2.1 (Fig. 8.8). NDUFS2 structure was modeled using the 3D CPH model 
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server (Nielsen, Lundegaard et al. 2010). The model that showed a pose close to the 
previously predicted orientation was chosen. NDUFS2 interacts with MidA through 
electrostatic interactions, as verified by the CONTACTS program of CCP4 (Potterton, 
Briggs et al. 2003; Winn, Ballard et al. 2011). MidA residues Lys120, Glu121, 
Lys242, Gln334, Asn338, Lys342 and Lys399 form contacts with Asn20, Arg33, 
Gly22, Lys15, Ser40, Glu41 and Glu9 of NDUFS2 within 3.0 Å. However, an actual 





















CHAPTER 9. DISCUSSION 
 
MidA is conserved from bacteria to humans and it has a characteristic 
DUF185 motif of unknown function, as discussed in the results part 8.2.2. MidA from 
Dictyostelium and the one from human share significant sequence identity. The 
proposed methyltransferase property of this protein is likely to be important for 
mitochondrial Complex I function. Another putative methyltransferase, C20orf7 from 
human, has also been proposed to be inevitable for Complex I assembly (Sugiana, 
Pagliarini et al. 2008; Gerards, Sluiter et al. 2010). The presence of these 
methyltransferases certainly highlights the importance, but yet poorly defined role, of 
methylation in Complex I function. Overall 40% of inherited disorders related to the 
OXPHOS system are due to Complex I deficiencies.  
The direct role of MidA in human mitochondrial disorders is still unknown but 
it could be a strong candidate. The loss of function of MidA in Dictyostelium resulted 
in a complex phenotypic outcome, such as growth and developmental defects (Carilla-
Latorre, Gallardo et al. 2010). Dictyostelium midA
–
 null cells were found to have 
decreased activity of Complex I and Blue Native (BN) PAGE studies in human cells 
ascertain that the level of complex assembly goes down, when MidA level is down 
regulated, suggesting that MidA could have a role as an assembly factor (Carilla-
Latorre, Gallardo et al. 2010). Complex I (CI) is formed by about 45 subunits in 
humans. Chaperones have an important role in the assembly and stability of such a 
large multi protein complex and presently about six such assembly factors, including 
NDUFAF1-NDUFAF4 (Hoefs, Dieteren et al. 2009; Saada, Vogel et al. 2009), 
C8ORF38 (Pagliarini, Calvo et al. 2008) and C20ORF7 (Gerards, Sluiter et al. 2010), 
have been identified and studied for their role in human CI deficiency. Despite its 
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large size, the basic catalytic core of CI is formed by only 14 proteins, which are 
evolutionarily conserved from prokaryotes to humans. All the 14 proteins, including 
NDUFS2 (Loeffen, Elpeleg et al. 2001; Ugalde, Janssen et al. 2004), are implicated in 
human CI disorders. NDUFS2 is an iron-sulfur protein and has been identified to 
interact with MidA. Even though NDUFS2 is highly homologous in human and 
Dictyostelium, it is encoded by the nuclear genome in humans whereas it is encoded 
by the mitochondrial genome in Dictyostelium, correlating its ancient origin as an 
endosymbiont protein. Surprisingly, proteobacteria are found to have MidA 
homologues, giving us a clear message that the MidA protein and the catalytic CI are 
of ancient origin and conserved from bacteria to humans. 
 Despite little sequence identity, SAM-dependent methyltransferase enzymes 
have a conserved structural fold.. Interestingly, the residues that bind the co-factor 
SAM are poorly conserved (Schubert, Blumenthal et al. 2003; Loenen 2006). Our 
crystal structure and several structural features support that that MidA could act as a 
methyltransferase. We suggest that MidA is a methyltransferase involved in SAM 
binding and could be involved in methylation of its substrate, probably the subunits of 
mitochondrial Complex I. The proteins that bind to SAM and catalyze a methyl 
transfer are classified into five groups and our structure fits into class I, the most 
abundant (Martin and McMillan 2002; Schubert, Blumenthal et al. 2003). Further 
biochemical characterization identification of targets are needed. 
Methyltransferases are involved in the methylation of various substrates, such 
as DNA, RNA, proteins and small molecules. The atomic targets are carbon, oxygen, 
nitrogen and sulfur. In most cases, no specific signature in the sequence or structure of 
methyltransferase proteins can be employed to predict substrates. For example, motif 
I is found in DNA, RNA, protein and small molecule methyltransferases (Kagan and 
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Clarke 1994). Methylation has an important role in the mitochondrion, since the 
targets of specific methylation events are mitochondrial DNA, tRNA and rRNA 
(Helm, Brulé et al. 1998) and there are specific carriers to transport SAM into the 
mitochondrion (Palmieri, Arrigoni et al. 2006). Protein methylation is also of 
importance in cell signaling. Only two methylated subunits have been found in 
mitochondrial complex I subunits. Bovine NDUFB3 (B12), which is methylated at 
conserved His residues and human NDUFS2, which is methylated at Arg323 (Carilla-
Latorre, Gallardo et al. 2010). Indeed, the possible hypothesis would be that MidA 
interacts with NDUFS2 and methylates it. However this hypothesis needs adequate 
experimental validation. The importance of such mitochondrial methylation is not 
known yet, but such modification of important core member of Complex I might carry 
a lot of relevance in mitochondrial function.  
The role of MidA in Complex I assembly and its interaction with the NDUFS2 
subunit of complex I has been reported earlier (Carilla-Latorre, Gallardo et al. 2010), 
and based on our structure, it could be understood that it binds to SAM with its 
conserved motif I and might function as a methyltransferase. It is also possible to 
project that MidA can possibly have dual functions as a chaperone and a 
methyltransferase. Based on our docking model, it can be speculated that the N-
terminus of MidA makes contact with its C-terminus, in addition to binding the co-
factor SAM, to interact with NDUFS2. This hypothesis needs to be supported by 
experimental evidences. It confers the possibility of the substrate binding region 
existing as a separate domain and the co-factor binding regions existing as a separate 
unit which would help MidA binding and methylating its substrate it. In case of 
certain methyltransferases reported earlier, where substrates are known such as 
Ribosome binding methyltransferase, which tend to have separate catalytic domain 
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other than the co-factor binding region (Husain, Tkaczuk et al. 2010; Husain, Obranic 
et al. 2011). In case of MidA, it possibly follows the same mechanism, but the 
specificity towards substrate will be known only after confirming the substrate and 
interaction with it. Our model is in accordance with the interaction study results 
(Carilla-Latorre, Gallardo et al. 2010). Importantly, MidA is not stably bound to CI as 
shown by BN-PAGE (Carilla-Latorre, Gallardo et al. 2010). Thus it may be possible 
that MidA, as a protein methyltransferase, interacts with and methylates NDUFS2 
during the assembly process of the complex as a transitory protein that is required for 
correct Complex I formation and then leaves. Crystal structure determination of the 
MidA:NDUFS2 complex, additional mutational studies of relevant MidA and 
NDUFS2 residues and identification of specific targets of MidA will give better more 
details about the mode of interaction of MidA and NDUFS2 and their roles in 















CHAPTER 10. CONCLUSION AND FUTURE PERSPECTIVES 
 
 In this thesis, I have reported the details of my studies on two proteins that are 
involved in gene regulation and cell signaling. Here I am adding the conclusion and 
future direction, separately for both the proteins. 
10.1 NMR STUDY OF TRD 
 The TRD domain of MBD1 has been known to be highly important for gene 
repression by recruiting several repressor proteins to a gene promoter. TRD by itself, 
even in the absence of the other domains of MBD1, is sufficient enough to suppress a 
gene, as demonstrated when it was fused to the GAL4 DNA binding domain to 
facilitate localizing to any promoter. Little was known about its structural features and 
how it recruits multiple proteins with high specificity. The NMR technique was 
employed to study the structural feature of TRD of MBD1 and it was surprisingly 
found to be an intrinsically unstructured protein with negligible secondary structure. 
Interestingly, it was found to be interacting with its binding partners in a specific 
manner, since NMR titration against the binding partners showed that the mode of 
binding is specific for particular proteins. GST pull-down, based on the NMR 
titration, showed that particular residues of TRD favor binding to certain proteins. 
MCAF1Δ8 is found to be interacting with TRD in a stronger manner than MPG and 
even a single mutation of TRD could prevent MPG interaction with TRD, whereas 
MCAF1Δ8 could still interact with TRD. Similarly, the binding affinities, based on 
ITC, showed that MCAF1Δ8 interacts stronger than MPG. Thus it can be implied that 
TRD interacts in a specific, but transient, manner with its binding partners. After 




 The future direction is to study the importance of the stretch of residues and 
identify the individual amino acids that are involved in interaction with MCAF1Δ8 
and MPG using cell based studies. Site-directed mutations of important residues of 
TRD of MBD1, based on the current study and check the level of co-localization and 
suppressor activity, in the presence of MCAF1 and MPG, is also a potential future 
extension. This study helps us expand the knowledge of the functional importance of 
intrinsically unstructured proteins in cell signaling. 
 
10.2 CRYSTAL STRUCTURE OF MIDA 
 MidA was first identified to be important for mitochondrial complex I 
assembly and interacts with the NDUFS2 subunit of it. It was also proposed to be a 
methyltransferase, since it has the conserved SAM binding region. Its mutants were 
unable to bind SAM and Dictyosteium MidA
-
 cells could be rescued with those 
mutants. However, the above study did not report a structural basis. Apo MidA and in 
complex with co-factors SAM and SAH were crystallized and the structure was 
determined using X-ray crystallography. The important residues that are involved in 
recognizing SAM were identified. While it could be proposed with confidence, based 
on the structure, that MidA is a methyltransferase, its substrate is still not known. 
Based on the earlier reports that the N-terminus of NDUFS2 interacts with MidA, we 
have prepared a docking model of MidA with NDUSF2 and shown that the 
interaction is mostly through charged residues.  Thus the MidA structure justifies it to 
be a methyltransferase; it recognizes SAM with its conserved SAM binding motif and 
interacts with NDUFS2. The future direction for this study would be to prove that 
NDUFS2 is the substrate of MidA and also to determine its other substrates. Once 
identified, the importance of MidA, as a methyltransferase, can be established by 
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performing several in vivo studies and showing how important is the methylation of 
such substrates by MidA and what are the subsequent changes endured when the 
methylation is affected. Also, it is of high interest to know the complex structure of 
MidA-NDUFS2 by X-ray crystallography which will gives us an idea on how MidA 
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